Myocardium

• 

  Subject Areas on Research

  • "Targeting the Heart" in Heart Failure: Myocardial Recovery in Heart Failure With Reduced Ejection Fraction. 
  • (3H)-Propranolol binding sites in myocardial membranes: nonidentity with beta adrenergic receptors. 
  • (3H)norepinephrine binding: unrelated to catechol-O-methyl transferase. 
  • (4-[18F]fluoro-3-iodobenzyl)guanidine, a potential MIBG analogue for positron emission tomography. 
  • 3-Deazaguanine: report of a phase I trial and drug-related cardiac toxicity. 
  • 4-Hydroxy-2(E)-nonenal (HNE) catabolism and formation of HNE adducts are modulated by β oxidation of fatty acids in the isolated rat heart. 
  • A carbon monoxide irreducible form of cytochrome c oxidase and other unusual properties of the "monomeric" shark enzyme. 
  • A comprehensive guide to genetic variants and post-translational modifications of cardiac troponin C. 
  • A computer based index for the prediction of operative survival in patients with cirrhosis and portal hypertension. 
  • A computer model of engineered cardiac monolayers. 
  • A deadly game of musical chairs: survival of cells transplanted for myocardial repair. 
  • A dual role for ErbB2 signaling in cardiac trabeculation. 
  • A dynamic epicardial injury response supports progenitor cell activity during zebrafish heart regeneration. 
  • A fraction of the ventricular myocardium that has the specificity of the cardiac beta-adrenergic receptor. 
  • A high-resolution cardiovascular magnetic resonance diffusion tensor map from ex-vivo C57BL/6 murine hearts. 
  • A historical perspective on the discovery of adenyl purines. 
  • A kinetic investigation of the interaction of alpha-methylaspartic acid with aspartate aminotransferase. 
  • A kinetic study of the binding of an ADP fluorescent analog to mitochondrial ATPase. 
  • A magnetization-driven gradient echo pulse sequence for the study of myocardial perfusion. 
  • A method for assembling a collaborative research team from multiple disciplines and academic centers to study the relationships between ECG estimation and MRI measurement of myocardial infarct size. 
  • A method to measure myocardial calcium handling in adult Drosophila. 
  • A mutation in TNNC1-encoded cardiac troponin C, TNNC1-A31S, predisposes to hypertrophic cardiomyopathy and ventricular fibrillation. 
  • A new cardiac MASTer switch for the renin-angiotensin system. 
  • A normothermic ex vivo organ perfusion delivery method for cardiac transplantation gene therapy. 
  • A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: design of the RENEW study. 
  • A phorbol ester augments cAMP content and adenylyl cyclase activity in neonatal rat cardiac myocytes despite reduced beta adrenoceptor density. 
  • A possible subcellular structure based on the macroscopic cardiac source. 
  • A quantitative measurement of spatial order in ventricular fibrillation. 
  • A rapid method of staining ultrathin sections for surgical pathology TEM with the use of the microwave oven. 
  • A reappraisal of loop diuretic choice in heart failure patients. 
  • A requirement for the rac1 GTPase in the signal transduction pathway leading to cardiac myocyte hypertrophy. 
  • A role for Sp and nuclear receptor transcription factors in a cardiac hypertrophic growth program. 
  • A sensitivity analysis of enzymatic estimation of infarct size. 
  • A six-month-old boy with neonatal lupus and cardiac enlargement. 
  • A source of bias in the analysis of single channel data: assessing the apparent interaction between channel proteins. 
  • A theoretical analysis of acute ischemia and infarction using ECG reconstruction on a 2-D model of myocardium. 
  • AAV CRISPR editing rescues cardiac and muscle function for 18 months in dystrophic mice. 
  • ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. 
  • AN OPTICAL ROTATORY DISPERSION STUDY OF ASPARTIC AMINO TRANSFERASE. 
  • Ablation of the secondary heart field leads to tetralogy of Fallot and pulmonary atresia. 
  • Abnormal cardiac Na(+) channel properties and QT heart rate adaptation in neonatal ankyrin(B) knockout mice. 
  • Abnormal cardiac enzyme responses after strenuous exercise: alternative diagnostic aids. 
  • Abnormalities of cardiac sympathetic function in pacing-induced heart failure as assessed by [123I]metaiodobenzylguanidine scintigraphy. 
  • Aborted myocardial infarction after primary percutaneous coronary intervention: magnetic resonance imaging insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial. 
  • Accelerated Marfan syndrome model recapitulates established signaling pathways. 
  • Accelerated development of rat sympathetic neurotransmission caused by neonatal triiodothyronine administration. 
  • Activation in unipolar cardiac electrograms: a frequency analysis. 
  • Activation of beef heart mitochondrial adenosine triphosphatase by 2,4-dinitrophenol. 
  • Acute brain death alters left ventricular myocardial gene expression. 
  • Acute effects of cocaine on ornithine decarboxylase activity in fetal and neonatal rat heart: evidence for cardiotoxicity. 
  • Acute effects of ethanol on myocardial blood flow in the nonischemic and ischemic heart. 
  • Acute fulminant myocarditis: long-term follow-up after circulatory support with left ventricular assist device. 
  • Acute myocardial beta-adrenergic receptor dysfunction after cardiopulmonary bypass in patients with cardiac valve disease. Duke Heart Center Perioperative Desensitization Group. 
  • Adaptive mechanisms that preserve cardiac function in mice without myoglobin. 
  • Adenovirus-mediated gene transfer of the beta2-adrenergic receptor to donor hearts enhances cardiac function. 
  • Adenylate cyclase-coupled beta-adrenergic receptors: structure and mechanisms of activation and desensitization. 
  • Adolescent nicotine exposure alters cardiac autonomic responsiveness: beta-adrenergic and m2-muscarinic receptors and their linkage to adenylyl cyclase. 
  • Adolescents and adults differ in the immediate and long-term impact of nicotine administration and withdrawal on cardiac norepinephrine. 
  • Adrenergic modulation of cardiac development in the rat: effects of prenatal exposure to propranolol via continuous maternal infusion. 
  • Adrenergic receptors in the heart. 
  • Affinity chromatography of beta-hydroxybutyrate dehydrogenase on Nad and hydrophobic chain derivatives of sepharose. 
  • Age increases cardiac Galpha(i2) expression, resulting in enhanced coupling to G protein-coupled receptors. 
  • Age increases expression and receptor-mediated activation of G alpha i in human atria. 
  • Age-dependent changes in expression of alpha 1-adrenergic receptors in rat myocardium. 
  • Age-dependent functional crosstalk between cardiac fibroblasts and cardiomyocytes in a 3D engineered cardiac tissue. 
  • Agonist-dependent recruitment of phosphoinositide 3-kinase to the membrane by beta-adrenergic receptor kinase 1. A role in receptor sequestration. 
  • Akt/protein kinase B promotes organ growth in transgenic mice. 
  • Alpha-2 adrenergic receptors stimulate actin organization in developing fetal rat cardiac myocytes. 
  • Alpha-adrenergic receptors in rat myocardium. Identification by binding of [3H]dihydroergocryptine. 
  • Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy. 
  • Alterations in the development of catecholamine turnover induced by perinatal methadone: differences in central vs. peripheral sympathetic nervous systems. 
  • Altered Nulling of Myocardium and Blood Pool. 
  • Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy. 
  • Altered phosphate metabolism in myocardial infarction: P-31 MR spectroscopy. 
  • Amiodarone and reperfusion ventricular fibrillation. 
  • An ECG index of myocardial scar enhances prediction of defibrillator shocks: an analysis of the Sudden Cardiac Death in Heart Failure Trial. 
  • An FGF autocrine loop initiated in second heart field mesoderm regulates morphogenesis at the arterial pole of the heart. 
  • An SOD mimic protects NADP+-dependent isocitrate dehydrogenase against oxidative inactivation. 
  • An experimental model of chronic myocardial hibernation. 
  • An in vitro assessment of acoustic radiation force impulse imaging for visualizing cardiac radiofrequency ablation lesions. 
  • An increase in the myocardial PCr/ATP ratio in GLUT4 null mice. 
  • An interaction between tremorine and various autonomic agents on cardiac norepinephrine in the rat. 
  • An intrinsic adrenergic system in mammalian heart. 
  • An off-the-shelf artificial cardiac patch improves cardiac repair after myocardial infarction in rats and pigs. 
  • Analyses of Calcium-Independent Phospholipase A2beta (iPLA2β) in Biological Systems. 
  • Analysis of oxygen transport in a diffusion-limited model of engineered heart tissue. 
  • Analysis of pH gradients resulting from mass transport limitations in engineered heart tissue. 
  • Angiogenesis in fatal acute Kawasaki disease coronary artery and myocardium. 
  • Angiotensin AT1 receptor inhibition. Effects on hypertrophic remodeling and ACE expression in rats with pressure-overload hypertrophy due to ascending aortic stenosis. 
  • Angiotensin II blockade followed by growth hormone as adjunctive therapy after experimental myocardial infarction. 
  • Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. 
  • Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis. 
  • Ankyrin-B coordinates the Na/K ATPase, Na/Ca exchanger, and InsP3 receptor in a cardiac T-tubule/SR microdomain. 
  • Ankyrin-B is required for intracellular sorting of structurally diverse Ca2+ homeostasis proteins. 
  • Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. 
  • Ankyrin-based cardiac arrhythmias: a new class of channelopathies due to loss of cellular targeting. 
  • Antemortem diagnosis of an endomyocardial breast cancer metastasis by transvenous endomyocardial biopsy. 
  • Anti-beta(1)-adrenergic receptor antibodies and heart failure: causation, not just correlation. 
  • Antibody-Armed Platelets for the Regenerative Targeting of Endogenous Stem Cells. 
  • Apolipoprotein J/clusterin induction in myocarditis: A localized response gene to myocardial injury. 
  • Apoptosis and heart failure. 
  • Are developing beta-adrenoceptors able to desensitize? Acute and chronic effects of beta-agonists in neonatal heart and liver. 
  • Aspergillus myocarditis presenting as myocardial infarction with complete heart block. 
  • Assessment and Treatment of Patients With Type 2 Myocardial Infarction and Acute Nonischemic Myocardial Injury. 
  • Assessment of coronary reperfusion after thrombolysis with a model combining myoglobin, creatine kinase-MB, and clinical variables. TAMI-7 Study Group. Thrombolysis and Angioplasty in Myocardial Infarction-7. 
  • Assessment of myocardial lipomatous metaplasia using an optimized out-of-phase cine steady-state free-precession sequence: Validation and clinical implementation. 
  • Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation. 
  • Assessment of myocardial viability by cardiovascular magnetic resonance imaging. 
  • Assignment of human protein phosphatase 2A regulatory subunit genes b56alpha, b56beta, b56gamma, b56delta, and b56epsilon (PPP2R5A-PPP2R5E), highly expressed in muscle and brain, to chromosome regions 1q41, 11q12, 3p21, 6p21.1, and 7p11.2 --> p12. 
  • Association between short-term exposure to ambient fine particulate matter and myocardial injury in the CATHGEN cohort. 
  • Association of a 4-Tiered Classification of LV Hypertrophy With Adverse CV Outcomes in the General Population. 
  • Associations between Cardiac Magnetic Resonance T1 Mapping Parameters and Ventricular Arrhythmia in Patients with Chagas Disease. 
  • Asymmetrical electrically induced injury of rabbit ventricular myocytes. 
  • Atm deletion with dual recombinase technology preferentially radiosensitizes tumor endothelium. 
  • Atypical regulation of hepatic adenylyl cyclase and adrenergic receptors during a critical developmental period: agonists evoke supersensitivity accompanied by failure of receptor down-regulation. 
  • Augmentation of cardiac contractility mediated by the human beta(3)-adrenergic receptor overexpressed in the hearts of transgenic mice. 
  • Autologous CD34+ Cell Therapy for Refractory Angina: 2-Year Outcomes From the ACT34-CMI Study. 
  • Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trials. 
  • Autopsy findings with permanent pervenous pacemakers. 
  • BCVS scientific conference 2012 meeting report. 
  • BMP receptor IA is required in mammalian neural crest cells for development of the cardiac outflow tract and ventricular myocardium. 
  • Baroreflex Impairment Precedes Cardiometabolic Dysfunction in an Experimental Model of Metabolic Syndrome: Role of Inflammation and Oxidative Stress. 
  • Baseline Characteristics Predict the Presence of Amyloid on Endomyocardial Biopsy. 
  • Baseline NT-proBNP and biomarkers of inflammation and necrosis in patients with ST-segment elevation myocardial infarction: insights from the APEX-AMI trial. 
  • Basic concepts in cellular cardiac electrophysiology: Part I: Ion channels, membrane currents, and the action potential. 
  • Basic fibroblast growth factor is upregulated in hibernating myocardium. 
  • Bbeta-adrenergic receptor kinase-1 levels in catecholamine-induced myocardial hypertrophy: regulation by beta- but not alpha1-adrenergic stimulation. 
  • Beta adrenergic and muscarinic cholinergic receptors in canine myocardium. Effects of ischemia. 
  • Beta adrenoceptor recovery after heart failure in the dog. 
  • Beta-adrenergic control of c-fos expression in fetal and neonatal rat tissues: relationship to cell differentiation and teratogenesis. 
  • Beta-adrenergic receptors: biochemical mechanisms of physiological regulation. 
  • Beta-adrenoceptor control of G protein function in the neonate: determinant of desensitization or sensitization. 
  • Beta-adrenoceptor control of cardiac adenylyl cyclase during development: agonist pretreatment in the neonate uniquely causes heterologous sensitization, not desensitization. 
  • Beta-arrestin-mediated beta1-adrenergic receptor transactivation of the EGFR confers cardioprotection. 
  • Beta-arrestin-mediated signaling in the heart. 
  • Beta-arrestins: multifunctional cellular mediators. 
  • Beta1-adrenergic receptors stimulate cardiac contractility and CaMKII activation in vivo and enhance cardiac dysfunction following myocardial infarction. 
  • Beta2-adrenergic receptor overexpression in the developing mouse heart: evidence for targeted modulation of ion channels. 
  • Bidirectional Changes in Myocardial 18F-Fluorodeoxyglucose Uptake After Human Ventricular Unloading. 
  • Binding of catecholamines to receptors in cultured myocardial cells. 
  • Biochemical and structural changes in cultured heart cells induced by metabolic inhibition. 
  • Biochemical characterization of the Ca2+ release channel of skeletal and cardiac sarcoplasmic reticulum. 
  • Biochemical determinants of growth sparing during neonatal nutritional deprivation or enhancement: ornithine decarboxylase, polyamines, and macromolecules in brain regions and heart. 
  • Biological activity of agarose-immobilized catecholamines. 
  • Biomarkers in atrial fibrillation: investigating biologic plausibility, cause, and effect. 
  • Biomarkers of myocardial stress and fibrosis as predictors of mode of death in patients with chronic heart failure. 
  • Biomaterializing the promise of cardiac tissue engineering. 
  • Block and modulation of cardiac Na+ channels by antiarrhythmic drugs, neurotransmitters and hormones. 
  • Block of wild-type and inactivation-deficient cardiac sodium channels IFM/QQQ stably expressed in mammalian cells. 
  • Blockade of cardiac sodium channels by amitriptyline and diphenylhydantoin. Evidence for two use-dependent binding sites. 
  • Blockade of cardiac sodium channels by lidocaine. Single-channel analysis. 
  • Blockade of cardiac sodium channels. Competition between the permeant ion and antiarrhythmic drugs. 
  • Both selenium deficiency and modest selenium supplementation lead to myocardial fibrosis in mice via effects on redox-methylation balance. 
  • Branched chain amino acid metabolic reprogramming in heart failure. 
  • Building and re-building the heart by cardiomyocyte proliferation. 
  • C/EBPβ controls exercise-induced cardiac growth and protects against pathological cardiac remodeling. 
  • COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets. 
  • Ca2+/calmodulin-dependent protein kinase II (CaMKII) regulates cardiac sodium channel NaV1.5 gating by multiple phosphorylation sites. 
  • CaGE: cardiac gene expression knowledgebase. 
  • Calcineurin signaling in human cardiac hypertrophy. 
  • Calcium dependent CAMTA1 in adult stem cell commitment to a myocardial lineage. 
  • Calcium depletion and repletion in cultured chick heart muscle cells. 
  • Calmodulin-cardiac troponin C chimeras. Effects of domain exchange on calcium binding and enzyme activation. 
  • Carbon monoxide actuates O(2)-limited heme degradation in the rat brain. 
  • Cardiac Fibroblasts Adopt Osteogenic Fates and Can Be Targeted to Attenuate Pathological Heart Calcification. 
  • Cardiac GPCRs: GPCR signaling in healthy and failing hearts. 
  • Cardiac MR for the assessment of myocardial viability. 
  • Cardiac MRI to Visualize Myocardial Damage after ST-Segment Elevation Myocardial Infarction: A Review of Its Histologic Validation. 
  • Cardiac Magnetic Resonance Scar Imaging for Sudden Cardiac Death Risk Stratification in Patients with Non-Ischemic Cardiomyopathy. 
  • Cardiac Stem Cell Patch Integrated with Microengineered Blood Vessels Promotes Cardiomyocyte Proliferation and Neovascularization after Acute Myocardial Infarction. 
  • Cardiac adrenergic receptors. 
  • Cardiac alpha-adrenergic receptor expression is regulated by thyroid hormone during a critical developmental period. 
  • Cardiac and muscle fatigue due to relative functional overload induced by excessive stimulation, hypersensitive excitation-contraction coupling, or diminished performance capacity correlates with sarcoplasmic reticulum failure. 
  • Cardiac beta ARK1 inhibition prolongs survival and augments beta blocker therapy in a mouse model of severe heart failure. 
  • Cardiac cell toxicity induced by 4-hydroperoxycyclophosphamide is modulated by glutathione. 
  • Cardiac copper deficiency activates a systemic signaling mechanism that communicates with the copper acquisition and storage organs. 
  • Cardiac cryosurgery: effects of myocardial temperature on cryolesion size. 
  • Cardiac evaluation of mitoxantrone. 
  • Cardiac fibroblast paracrine factors alter impulse conduction and ion channel expression of neonatal rat cardiomyocytes. 
  • Cardiac fibroblasts in pressure overload hypertrophy: the enemy within? 
  • Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. 
  • Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. 
  • Cardiac gene delivery with cardiopulmonary bypass. 
  • Cardiac micro-computed tomography for morphological and functional phenotyping of muscle LIM protein null mice. 
  • Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. 
  • Cardiac overexpression of a G(q) inhibitor blocks induction of extracellular signal-regulated kinase and c-Jun NH(2)-terminal kinase activity in in vivo pressure overload. 
  • Cardiac phenotype and angiotensin II levels in AT1a, AT1b, and AT2 receptor single, double, and triple knockouts. 
  • Cardiac propagation simulation. 
  • Cardiac regeneration strategies: Staying young at heart. 
  • Cardiac renin-angiotensin system. Molecular and functional aspects. 
  • Cardiac sarcoidosis: two cases with autopsy findings. 
  • Cardiac tissue engineering using stem cells. 
  • Cardiac transplantation in a pediatric patient with systemic sclerosis. 
  • Cardiac troponins in congestive heart failure. 
  • Cardiac vulnerability to ischemia/reperfusion injury drastically increases in late pregnancy. 
  • Cardiac-specific LIM protein FHL2 modifies the hypertrophic response to beta-adrenergic stimulation. 
  • Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. 
  • Cardiac-specific mindin overexpression attenuates cardiac hypertrophy via blocking AKT/GSK3β and TGF-β1-Smad signalling. 
  • Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects. 
  • Cardiomyocyte cultures with controlled macroscopic anisotropy: a model for functional electrophysiological studies of cardiac muscle. 
  • Cardiomyopathy in Friedreich's Ataxia. 
  • Cardiopatch platform enables maturation and scale-up of human pluripotent stem cell-derived engineered heart tissues. 
  • Cardioprotective and antiapoptotic effects of heme oxygenase-1 in the failing heart. 
  • Cardioprotective effects of 70-kDa heat shock protein in transgenic mice. 
  • Cardioprotective role of S-nitrosylated hemoglobin from rbc. 
  • Cardiorespiratory fitness in breast cancer patients: a call for normative values. 
  • Cardiospecific creatine kinase after strenuous exercise in female athletes. 
  • Cardiotoxicity From Human Epidermal Growth Factor Receptor-2 (HER2) Targeted Therapies. 
  • Cardiovascular Metabolomics. 
  • Catabolism of (2E)-4-hydroxy-2-nonenal via ω- and ω-1-oxidation stimulated by ketogenic diet. 
  • Catecholamine stimulated myocardial adenylate cyclase: effects of nucleotides. 
  • Catecholamine stimulated myocardial adenylate cyclase: effects of phospholipase digestion and the role of membrane lipids. 
  • Catecholamine synthesis is mediated by tyrosinase in the absence of tyrosine hydroxylase. 
  • Catecholamines, cardiac beta-adrenergic receptors, and heart failure. 
  • Catheter-based intracoronary myocardial adenoviral gene delivery: importance of intraluminal seal and infusion flow rate. 
  • Catheter-mediated subselective intracoronary gene delivery to the rabbit heart: introduction of a novel method. 
  • Cell cycle control in the terminally differentiated myocyte. A platform for myocardial repair? 
  • Cell size and communication: role in structural and electrical development and remodeling of the heart. 
  • Cell therapy for heart failure: the need for a new therapeutic strategy. 
  • Cellular Vmax reflects both membrane properties and the load presented by adjoining cells. 
  • Cellular and functional defects in a mouse model of heart failure. 
  • Cellular and molecular alterations in the beta adrenergic system with cardiomyopathy induced by tachycardia. 
  • Cellular cardiomyoplasty improves diastolic properties of injured heart. 
  • Cellular mechanisms for developmental toxicity of chlorpyrifos: targeting the adenylyl cyclase signaling cascade. 
  • Cellular models of hibernating myocardium: implications for future research. 
  • Central catecholaminergic lesions in the developing rat: effects of cardiac noradrenaline levels, turnover and release. 
  • Central sympathetic blockade ameliorates brain death-induced cardiotoxicity and associated changes in myocardial gene expression. 
  • Changes in anisotropic conduction caused by remodeling cell size and the cellular distribution of gap junctions and Na(+) channels. 
  • Changes in cardiac troponin T measurements are associated with adverse cardiac events in patients with chronic kidney disease. 
  • Changes in diastolic cardiac function in developing and stable perinephritic hypertension in conscious dogs. 
  • Changes in gravitational force induce alterations in gene expression that can be monitored in the live, developing zebrafish heart. 
  • Changes in macroautophagy, chaperone-mediated autophagy, and mitochondrial metabolism in murine skeletal and cardiac muscle during aging. 
  • Changing the diagnosis of acute myocardial infarction: implications for practice and clinical investigations. 
  • Characteristics of 5'-guanylyl imidodiphosphate-activated adenylate cyclase. 
  • Characteristics of corneal xenograft rejection in a discordant species combination. 
  • Characterization of a spectrophotometric assay for cAMP phosphodiesterase. 
  • Characterization of cardiac A1 adenosine receptors by ligand binding and photoaffinity labeling. 
  • Characterizing activity-dependent processes with a piecewise exponential model. 
  • Characterizing the contribution of cardiac and hepatic uptake in dedicated breast SPECT using tilted trajectories. 
  • Chemical cross-linking studies of beef heart mitochondrial coupling factor 1. 
  • Chimeric calmodulin-cardiac troponin C proteins differentially activate calmodulin target enzymes. 
  • Cholinergic receptors in heart and brainstem of rats exposed to nicotine during development: implications for hypoxia tolerance and perinatal mortality. 
  • Chromosome 4q25 variants and biomarkers of myocardial fibrosis in patients with atrial fibrillation. 
  • Chronic N(G)-nitro-L-arginine methyl ester-induced hypertension : novel molecular adaptation to systolic load in absence of hypertrophy. 
  • Chronic guanethidine treatment increases cardiac beta-adrenergic receptors. 
  • Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy. 
  • Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy. 
  • Chronic recurrent myocardial ischemic injury is significantly attenuated by pre-emptive adeno-associated virus heme oxygenase-1 gene delivery. 
  • Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery. 
  • Cine MR determination of left ventricular ejection fraction. 
  • Clinical pathway to screen for cardiac amyloidosis in heart failure with preserved ejection fraction. 
  • Clinical significance of intermediate left ventricular trabeculations in cardiac magnetic resonance. 
  • Clinical utility of serial and continuous ST-segment recovery assessment in patients with acute ST-elevation myocardial infarction: assessing the dynamics of epicardial and myocardial reperfusion. 
  • Clonally dominant cardiomyocytes direct heart morphogenesis. 
  • Cloning and characterization of cytokeratins 8 and 19 in adult rat striated muscle. Interaction with the dystrophin glycoprotein complex. 
  • Clopidogrel loading with eptifibatide to arrest the reactivity of platelets: results of the Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets (CLEAR PLATELETS) study. 
  • Coenzyme Q10 and Heart Failure: A State-of-the-Art Review. 
  • Combined immunodeficiency disease associated with adenosine deaminase deficiency. Report on a workshop held in Albany, New York, October 1, 1973. 
  • Combining necrosis and platelet markers for perfecting myocardial infarction rule out: how close are we? 
  • Comparative stereology of the lizard and frog myocardium. 
  • Comparative stereology of the mouse and finch left ventricle. 
  • Comparative studies of prosthetic materials in the left atrium of the dog. 
  • Comparison of activation during ventricular fibrillation and following unsuccessful defibrillation shocks in open-chest dogs. 
  • Comparison of benefits on myocardial performance of cellular cardiomyoplasty with skeletal myoblasts and fibroblasts. 
  • Comparison of cardiac troponin T versus creatine kinase-MB for risk stratification in a chest pain evaluation unit. 
  • Comparison of myocardial protection with nifedipine and potassium. 
  • Compartmentation of Metabolism of the C12-, C9-, and C5-n-dicarboxylates in Rat Liver, Investigated by Mass Isotopomer Analysis: ANAPLEROSIS FROM DODECANEDIOATE. 
  • Comprehensive metabolic modeling of multiple 13C-isotopomer data sets to study metabolism in perfused working hearts. 
  • Compressed sensing reconstruction for undersampled breath-hold radial cine imaging with auxiliary free-breathing data. 
  • Conduction block after cardioplegic arrest: prevention by augmented atrial hypothermia. 
  • Congenital generalized fibromatosis with visceral involvement. A case report. 
  • Consequences of growth hormone deficiency on cardiac structure, function, and beta-adrenergic pathway: studies in mutant dwarf rats. 
  • Contrast-enhanced magnetic resonance imaging identifies focal regions of intramyocardial fibrosis in patients with severe aortic valve disease: Correlation with quantitative histopathology. 
  • Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. 
  • Contributions of beta2-microglobulin-dependent molecules and lymphocytes to iron regulation: insights from HfeRag1(-/-) and beta2mRag1(-/-) double knock-out mice. 
  • Control of adenylate cyclase activity in developing rat heart and liver: effects of prenatal exposure to terbutaline or dexamethasone. 
  • Control of electrical alternans in simulations of paced myocardium using extended time-delay autosynchronization. 
  • Control of myocardial contractile function by the level of beta-adrenergic receptor kinase 1 in gene-targeted mice. 
  • Control of nucleic acid and protein synthesis in developing brain, kidney, and heart of the neonatal rat: effects of alpha-difluoromethylornithine, a specific, irreversible inhibitor of ornithine decarboxylase. 
  • Controlling the structural and functional anisotropy of engineered cardiac tissues. 
  • Convergences of Life Sciences and Engineering in Understanding and Treating Heart Failure. 
  • Coronary Slow Flow Phenomenon - Adding Myocardial Fibrosis to the Equation. 
  • Correction of glycogen storage disease type II by an adeno-associated virus vector containing a muscle-specific promoter. 
  • Correction of multiple striated muscles in murine Pompe disease through adeno-associated virus-mediated gene therapy. 
  • Correlation of agonist-induced phosphorylation of chick heart muscarinic receptors with receptor desensitization. 
  • Coupled sodium-calcium transport in cultured chick heart cells. 
  • Coupling of beta2-adrenoceptor to Gi proteins and its physiological relevance in murine cardiac myocytes. 
  • Creatine kinase overexpression improves ATP kinetics and contractile function in postischemic myocardium. 
  • Creatine kinase-overexpression improves myocardial energetics, contractile dysfunction and survival in murine doxorubicin cardiotoxicity. 
  • Creatinine kinase kinetics studied by phosphorus-31 nuclear magnetic resonance in a canine model of chronic hypertension-induced cardiac hypertrophy. 
  • Cultured thymus tissue implantation promotes donor-specific tolerance to allogeneic heart transplants. 
  • Current density and electrically induced ventricular fibrillation. 
  • Current density and electrically induced ventricular fibrillation. 
  • Cytochrome P450IA1 induction and localization in endothelium of vertebrate (teleost) heart. 
  • Cytokine mRNA expression in postischemic/reperfused myocardium. 
  • Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28. 
  • Dark-Blood Delayed Enhancement Cardiac Magnetic Resonance of Myocardial Infarction. 
  • Decoding the Long Noncoding RNA During Cardiac Maturation: A Roadmap for Functional Discovery. 
  • Decreased beta-adrenergic responsiveness following hypertrophy occurs only in cardiomyocytes that also re-express beta-myosin heavy chain. 
  • Decreased expression of tissue inhibitor of metalloproteinase 1 in stunned myocardium. 
  • Degradation of spectrin and ankyrin in the ischemic rat kidney. 
  • Deletion of MLIP (muscle-enriched A-type lamin-interacting protein) leads to cardiac hyperactivation of Akt/mammalian target of rapamycin (mTOR) and impaired cardiac adaptation. 
  • Delivery of primary autologous skeletal myoblasts into rabbit heart by coronary infusion: a potential approach to myocardial repair. 
  • Demonstration of dissimilar acute haemodynamic effects of ethanol and acetaldehyde. 
  • Depletion of myocardial high energy phosphates by induction of ventricular fibrillation prior to cardioplegic arrest. 
  • Depressed high-energy phosphate content in hypertrophied ventricles of animal and man: the biologic basis for increased sensitivity to ischemic injury. 
  • Desensitization of myocardial beta-adrenergic receptors and deterioration of left ventricular function after brain death. 
  • Designing a Better Mousetrap: Reflections on the November 28, 2017, US Food and Drug Administration Meeting on Next-Generation "High-Sensitivity" Cardiac Troponin Assays to Diagnose Myocardial Infarction. 
  • Detecting Cardiovascular Protein-Protein Interactions by Proximity Proteomics. 
  • Detection, characterization and functional assessment of reperfused Q-wave acute myocardial infarction by cine magnetic resonance imaging. 
  • Determination of the primary structures of human skin chymase and cathepsin G from cutaneous mast cells of urticaria pigmentosa lesions. 
  • Development and cardiac contractility: cardiac troponin T isoforms and cytosolic calcium in rabbit. 
  • Development of a model of the coronary arterial tree for the 4D XCAT phantom. 
  • Development of central control of norepinephrine turnover and release in the rat heart: responses to tyramine, 2-deoxyglucose and hydralazine. 
  • Development of polyamine and biogenic amine systems in brains and hearts of neonatal rats given dexamethasone: role of biochemical alterations in cellular maturation for producing deficits in ontogeny of neurotransmitter levels, uptake, storage and turnover. 
  • Developmental effects of alpha-fluoromethylhistidine, an irreversible inhibitor of histidine decarboxylase, on growth and on levels and turnover of catecholamines. 
  • Developmental effects of chlorpyrifos extend beyond neurotoxicity: critical periods for immediate and delayed-onset effects on cardiac and hepatic cell signaling. 
  • Developmental expression of glycogenolytic enzymes in rabbit tissues: possible relationship to fetal lung maturation. 
  • Developmental pattern of DNA and proteins in brain, liver, lung and heart of rats given excess vitamin A postnatally. 
  • Developmental regulation of cytochrome oxidase subunit VIa isoforms in cardiac and skeletal muscle. 
  • Developmental shift from local to central control of norepinephrine release in the cardiac-sympathetic axis: effects of cocaine and related drugs. 
  • Developmental stage-dependent effects of cardiac fibroblasts on function of stem cell-derived engineered cardiac tissues. 
  • Diabetic cardiomyopathy and carnitine deficiency. 
  • Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. 
  • Diet and sex modify exercise and cardiac adaptation in the mouse. 
  • Dietary branched-chain amino acid restriction alters fuel selection and reduces triglyceride stores in hearts of Zucker fatty rats. 
  • Different roles for matrix metalloproteinase-2 and matrix metalloproteinase-9 in the pathogenesis of cardiac allograft rejection. 
  • Differential cardiac gene expression during cardiopulmonary bypass: ischemia-independent upregulation of proinflammatory genes. 
  • Differential expression of angiotensin receptor subtypes in the myocardium: a hypothesis. 
  • Differential ventricular ischemic injury: an experimental model of right ventricular failure with a variable degree of left ventricular dysfunction. 
  • Differentiation of viable and nonviable myocardium by the use of three-dimensional tagged MRI in 2-day-old reperfused canine infarcts. 
  • Differentiation- and stress-dependent nuclear cytoplasmic redistribution of myopodin, a novel actin-bundling protein. 
  • Digoxin-induced positive exercise tests: their clinical and prognostic significance. 
  • Dilated cardiomyopathy in transgenic mice expressing a mutant A subunit of protein phosphatase 2A. 
  • Direct Actions of AT1 (Type 1 Angiotensin) Receptors in Cardiomyocytes Do Not Contribute to Cardiac Hypertrophy. 
  • Direct evidence that coronary perfusion affects diastolic myocardial mechanical properties in canine heart. 
  • Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice. 
  • Disruption of mindin exacerbates cardiac hypertrophy and fibrosis. 
  • Disruption of myofibrillar energy use: dual mechanisms that may contribute to postischemic dysfunction in stunned myocardium. 
  • Dissociation between early recovery of regional function and purine nucleotide content in postischaemic myocardium in the conscious dog. 
  • Distilling complexity to advance cardiac tissue engineering. 
  • Distinct gene expression profiles in adult mouse heart following targeted MAP kinase activation. 
  • Distinct mouse coronary anatomy and myocardial infarction consequent to ligation. 
  • Distinct origins and molecular mechanisms contribute to lymphatic formation during cardiac growth and regeneration. 
  • Distribution and function of cardiac angiotensin AT1- and AT2-receptor subtypes in hypertrophied rat hearts. 
  • Distribution and functional significance of cardiac angiotensin converting enzyme in hypertrophied rat hearts. 
  • Distribution kinetics of 3H--labeled p-phenylene diamine--a hair dye. 
  • Distribution of immunoreactive androgen-binding protein/sex hormone-binding globulin in tissues of the fetal rat. 
  • Distribution of proteasomes and of the five proteolytic activities in rat tissues. 
  • Divergent pathways mediate the induction of ANF transgenes in neonatal and hypertrophic ventricular myocardium. 
  • Do catecholamines contribute to the effects of neonatal hypoxia on development of brain and heart? Influence of concurrent alpha-adrenergic blockade on ornithine decarboxylase activity. 
  • Dobutamine stress echocardiography: experience in pediatric heart transplant recipients. 
  • Does concurrent or prior nicotine exposure interact with neonatal hypoxia to produce cardiac cell damage? 
  • Does initial shunt type for the Norwood procedure affect echocardiographic measures of cardiac size and function during infancy?: the Single Vventricle Reconstruction trial. 
  • Does terbutaline damage the developing heart? 
  • Donor fraction cell-free DNA and rejection in adult and pediatric heart transplantation. 
  • Dose dependent effects of cardiac beta2 adrenoceptor gene therapy. 
  • Dose-dependent effect of prenatal dexamethasone treatment on beta-adrenergic receptor coupling to ornithine decarboxylase and cyclic AMP. 
  • Drosophila as a model for the identification of genes causing adult human heart disease. 
  • Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytes. 
  • Duality of innate stress responses in cardiac injury, repair, and remodeling. 
  • Dynamic denitrosylation via S-nitrosoglutathione reductase regulates cardiovascular function. 
  • Dynamic docking and electron-transfer between cytochrome b5 and a suite of myoglobin surface-charge mutants. Introduction of a functional-docking algorithm for protein-protein complexes. 
  • Dynamic mechanisms of cardiac oxygenation during brief ischemia and reperfusion. 
  • Dysregulation of multiple facets of glycogen metabolism in a murine model of Pompe disease. 
  • ENU mutagenesis identifies mice with cardiac fibrosis and hepatic steatosis caused by a mutation in the mitochondrial trifunctional protein beta-subunit. 
  • ERRgamma regulates cardiac, gastric, and renal potassium homeostasis. 
  • Early beneficial effects of bone marrow-derived mesenchymal stem cells overexpressing Akt on cardiac metabolism after myocardial infarction. 
  • Early effects of right ventricular volume overload on ventricular performance and beta-adrenergic signaling. 
  • Early fetal hypoxia leads to growth restriction and myocardial thinning. 
  • Early impairment of myocardial deformation assessed by regional speckle-tracking echocardiography in the indeterminate form of Chagas disease without fibrosis detected by cardiac magnetic resonance. 
  • Early postoperative changes in left ventricular chamber size, architecture, and function in aortic stenosis and aortic regurgitation and their relation to intraoperative changes in afterload: a prospective two-dimensional echocardiographic study. 
  • Echocardiographic manifestations of Glycogen Storage Disease III: increase in wall thickness and left ventricular mass over time. 
  • Echocardiography for the assessment of myocardial viability. 
  • Effect of a dominant negative ras on myocardial hypertrophy by using adenoviral-mediated gene transfer. 
  • Effect of a purified diet on dystrophic cardiac calcinosis in mice. 
  • Effect of clopidogrel with and without eptifibatide on tumor necrosis factor-alpha and C-reactive protein release after elective stenting: results from the CLEAR PLATELETS 1b study. 
  • Effect of cyclical intermittent hypoxia on Ad5CMVCre induced solitary lung cancer progression and spontaneous metastases in the KrasG12D+; p53fl/fl; myristolated p110fl/fl ROSA-gfp mouse. 
  • Effect of feeding plant proteins on plasma, liver, heart, aorta and brain lipids of rats. 
  • Effect of heparin on vitamin A induced hyperlipidemia in rats. 
  • Effect of hyperbaric oxygenation on left ventricular function. 
  • Effect of junctional resistance on source-strength in a linear cable. 
  • Effect of maternal ethanol ingestion on neonatal rat brain and heart ornithine decarboxylase. 
  • Effect of p38 MAP kinases on contractility and ischemic injury in intact heart. 
  • Effect of steady illumination on the binding of carbon monoxide by carboxymethylated cytochrome c. 
  • Effects of cardiac glycosides on myocardial function and energetics in conscious dogs. 
  • Effects of delay in administration of potassium cardioplegia to the isolated rat heart. 
  • Effects of electroporation on transmembrane potential induced by defibrillation shocks. 
  • Effects of experimental diabetes on adrenergic and cholinergic receptors of rat myocardium. 
  • Effects of fetal dexamethasone exposure on postnatal control of cardiac adenylate cyclase: beta-adrenergic receptor coupling to Gs regulatory protein. 
  • Effects of growth hormone and IGF-I on cardiac hypertrophy and gene expression in mice. 
  • Effects of induced tolerance to bacterial lipopolysaccharide on myocardial infarct size in rats. 
  • Effects of late prenatal or early postnatal ethanol exposure on ornithine decarboxylase activity in brain and heart of developing rats. 
  • Effects of left ventricular assist device support on biomarkers of cardiovascular stress, fibrosis, fluid homeostasis, inflammation, and renal injury. 
  • Effects of maternal methadone administration on ornithine decarboxylase in brain and heart of the offspring: relationships of enzyme activity to dose and to growth impairment in the rat. 
  • Effects of monophasic and biphasic shocks on action potentials during ventricular fibrillation in dogs. 
  • Effects of myocardial infarction on the distribution and transport of nutrients and oxygen in porcine myocardium. 
  • Effects of myocardial water exchange on T1 enhancement during bolus administration of MR contrast agents. 
  • Effects of neonatal or maternal methadone administration on ornithine decarboxylase activity in brain and heart of developing rats. 
  • Effects of perchlorate on the molecules of excitation-contraction coupling of skeletal and cardiac muscle. 
  • Effects of physical conditioning on left ventricular ejection fraction in patients with coronary artery disease. 
  • Effects of propranolol on the hemodynamic, coronary sinus blood flow and myocardial metabolic response to atrial pacing. 
  • Effects of propranolol treatment on left ventricular function and intracellular calcium regulation in rats with postinfarction heart failure. 
  • Effects of specific activity on meta-[(131)I]iodobenzylguanidine kinetics in isolated rat heart. 
  • Effects of stimulation frequency on potassium activity and cell volume in cardiac tissue. 
  • Effects of temperature acclimation on Pacific bluefin tuna (Thunnus orientalis) cardiac transcriptome. 
  • Effects of the Novel Long-Acting GLP-1 Agonist, Albiglutide, on Cardiac Function, Cardiac Metabolism, and Exercise Capacity in Patients With Chronic Heart Failure and Reduced Ejection Fraction. 
  • Effects of water exchange on the measurement of myocardial perfusion using paramagnetic contrast agents. 
  • Efficient in vivo gene transfer into the heart in the rat myocardial infarction model using the HVJ (Hemagglutinating Virus of Japan)--liposome method. 
  • Efficient simulation of three-dimensional anisotropic cardiac tissue using an adaptive mesh refinement method. 
  • Ejection fraction in left bundle branch block is disproportionately reduced in relation to amount of myocardial scar. 
  • Electrical stimulation of neonatal cardiac myocytes activates the NFAT3 and GATA4 pathways and up-regulates the adenylosuccinate synthetase 1 gene. 
  • Electrophysiological effects of remodeling cardiac gap junctions and cell size: experimental and model studies of normal cardiac growth. 
  • Elevated beta-adrenergic receptor number after chronic propranolol treatment. 
  • Elevated skeletal muscle creatine kinase MB isoenzyme levels in marathon runners. 
  • Elucidating the molecular mechanism of cardiac remodeling using a comparative genomic approach. 
  • Embryonic cardiotoxicity of weak aryl hydrocarbon receptor agonists and CYP1A inhibitor fluoranthene in the Atlantic killifish (Fundulus heteroclitus). 
  • Endomyocardial Biopsy Characterization of Heart Failure With Preserved Ejection Fraction and Prevalence of Cardiac Amyloidosis. 
  • Endothelial nitric oxide synthase increases in left atria of dogs with pacing-induced heart failure. 
  • Endothelin activates voltage-dependent Ca2+ current by a G protein-dependent mechanism in rabbit cardiac myocytes. 
  • Endotoxin stress-response in cardiomyocytes: NF-kappaB activation and tumor necrosis factor-alpha expression. 
  • Energetics and metabolism in the failing heart: important but poorly understood. 
  • Engineered cardiac tissue patch maintains structural and electrical properties after epicardial implantation. 
  • Engineering Three-Dimensional Vascularized Cardiac Tissues. 
  • Engineering liver-detargeted AAV9 vectors for cardiac and musculoskeletal gene transfer. 
  • Enhanced Galphaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure. 
  • Enhanced calcium cycling and contractile function in transgenic hearts expressing constitutively active G alpha o* protein. 
  • Enhanced cardiac function in transgenic mice expressing a Ca(2+)-stimulated adenylyl cyclase. 
  • Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor. 
  • Enhanced myocardial relaxation in vivo in transgenic mice overexpressing the beta2-adrenergic receptor is associated with reduced phospholamban protein. 
  • Enhanced postischemic functional recovery in CYP2J2 transgenic hearts involves mitochondrial ATP-sensitive K+ channels and p42/p44 MAPK pathway. 
  • Enhanced response to enzyme replacement therapy in Pompe disease after the induction of immune tolerance. 
  • Enhancement of cardiac function after adenoviral-mediated in vivo intracoronary beta2-adrenergic receptor gene delivery. 
  • Enhancement of the recovery of rat hearts after prolonged cold storage by cyclocreatine phosphate. 
  • Equilibrium binding of nucleotides to beef heart mitochondrial adenosine triphosphatase. 
  • Erythroid-specific expression of human CD59 and transfer to vascular endothelial cells. 
  • Erythropoietin receptor expression in adult rat cardiomyocytes is associated with an acute cardioprotective effect for recombinant erythropoietin during ischemia-reperfusion injury. 
  • Essential role of AT1A receptor in the development of 2K1C hypertension. 
  • Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling. 
  • Essential role of beta-adrenergic receptor kinase 1 in cardiac development and function. 
  • Ethacizin blockade of calcium channels: a test of the guarded receptor hypothesis. 
  • Ethyl pyruvate improves survival in awake hemorrhage. 
  • Evaluation of SPECT quantification of radiopharmaceutical distribution in canine myocardium. 
  • Evaluation of a QRS scoring system for estimating myocardial infarct size. II. Correlation with quantitative anatomic findings for anterior infarcts. 
  • Evaluation of a QRS scoring system for estimating myocardial infarct size. IV. Correlation with quantitative anatomic findings for posterolateral infarcts. 
  • Evaluation of asynergy as an indicator of myocardial fibrosis. 
  • Evaluation of mechanical dyssynchrony and myocardial perfusion using phase analysis of gated SPECT imaging in patients with left ventricular dysfunction. 
  • Evaluation of the left ventricle with two dimensional echocardiography. 
  • Evaluation of the role of endomyocardial biopsy in 851 patients with unexplained heart failure from 2000-2009. 
  • Evidence for a Ca2+ channel within the ryanodine receptor complex from cardiac sarcoplasmic reticulum. 
  • Evidence for the existence of renin in the heart. 
  • Ex vivo adenovirus-mediated gene transfer to the adult rat heart. 
  • Excitation of a cardiac muscle fiber by extracellularly applied sinusoidal current. 
  • Exercise alters the regulation of myocardial Na(+)/H(+) exchanger-1 activity. 
  • Exercise can prevent and reverse the severity of hypertrophic cardiomyopathy. 
  • Exogenously administered growth hormone and insulin-like growth factor-I alter intracellular Ca2+ handling and enhance cardiac performance. In vitro evaluation in the isolated isovolumic buffer-perfused rat heart. 
  • Expanding CT Application to Myocardial Tissue Characterization. 
  • Expanding the Molecular Autopsy to Uncover Occult Cardiomyopathy: Concealed to Revealed. 
  • Experimental congestive heart failure produced by rapid ventricular pacing in the dog: cardiac effects. 
  • Exploring the role of the beta-adrenergic receptor kinase in cardiac disease using gene-targeted mice. 
  • Exposure to methylmercury in utero: effects on biochemical development of catecholamine neurotransmitter systems. 
  • Expression of heat shock proteins in myocardium of patients with atrial fibrillation. 
  • Expression of heme oxygenase-1 can determine cardiac xenograft survival. 
  • Expression of renin-angiotensin system and extracellular matrix genes in cardiovascular cells and its regulation through AT1 receptor. 
  • Extracellular space measurements with CMR imaging. 
  • Extracellular superoxide dismutase regulates cardiac function and fibrosis. 
  • Fast 23Na magnetic resonance imaging of acute reperfused myocardial infarction. Potential to assess myocardial viability. 
  • Feasibility of 19F imaging of perfluorochemical emulsions to measure myocardial vascular volume. 
  • Fetal dexamethasone exposure impairs cellular development in neonatal rat heart and kidney: effects on DNA and protein in whole tissues. 
  • Fetal nicotine exposure produces postnatal up-regulation of adenylate cyclase activity in peripheral tissues. 
  • Fibrillar collagen and remodeling of dilated canine left ventricle. 
  • Fibronectin is deposited by injury-activated epicardial cells and is necessary for zebrafish heart regeneration. 
  • Field stimulation of isolated chick heart cells: comparison of experimental and theoretical activation thresholds. 
  • Finding the road to recovery: therapeutic and clinical trial implications of dysfunctional viable myocardium in heart failure with reduced ejection fraction. 
  • Fine-mapping, novel loci identification, and SNP association transferability in a genome-wide association study of QRS duration in African Americans. 
  • First successful bridge to cardiac transplantation using direct mechanical ventricular actuation. 
  • First-pass entry of nonionic contrast agent into the myocardial extravascular space. Effects on radiographic estimates of transit time and blood volume. 
  • Focal adhesion kinase mediates the interferon-gamma-inducible GTPase-induced phosphatidylinositol 3-kinase/Akt survival pathway and further initiates a positive feedback loop of NF-kappaB activation. 
  • Frequency compounding for speckle contrast reduction in phased array images. 
  • Frontiers in electron probe microanalysis: application to cell physiology. 
  • Full-length dystrophin restoration via targeted exon integration by AAV-CRISPR in a humanized mouse model of Duchenne muscular dystrophy. 
  • Functional analysis of myocardial performance in murine hearts overexpressing the human beta 2-adrenergic receptor. 
  • Functional consequences of altering myocardial adrenergic receptor signaling. 
  • Functional equivalence of monomeric (shark) and dimeric (bovine) cytochrome c oxidase. 
  • Functional reentry in cultured monolayers of neonatal rat cardiac cells. 
  • Fundamental concepts in myocardial viability assessment revisited: when knowing how much is "alive" is not enough. 
  • Fusigenic liposome-mediated DNA transfer into cardiac myocytes. 
  • GIPC interacts with the beta1-adrenergic receptor and regulates beta1-adrenergic receptor-mediated ERK activation. 
  • Galactokinase is a novel modifier of calcineurin-induced cardiomyopathy in Drosophila. 
  • Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community. 
  • Gbetagamma-dependent phosphoinositide 3-kinase activation in hearts with in vivo pressure overload hypertrophy. 
  • Gene and cell-based therapies for heart disease. 
  • Gene signatures of postoperative atrial fibrillation in atrial tissue after coronary artery bypass grafting surgery in patients receiving β-blockers. 
  • Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene. 
  • Gene transfer and expression in rat cardiac transplants. 
  • Gene up-regulation in heart during mammalian hibernation. 
  • Generalized dual-energy-window scatter compensation in spatially varying media for SPECT. 
  • Genes for apolipoprotein B and microsomal triglyceride transfer protein are expressed in the heart: evidence that the heart has the capacity to synthesize and secrete lipoproteins. 
  • Genesis of the monophasic action potential: role of interstitial resistance and boundary gradients. 
  • Genetic Abrogation of Adenosine A3 Receptor Prevents Uninephrectomy and High Salt-Induced Hypertension. 
  • Genetic Dissection of Cardiac Remodeling in an Isoproterenol-Induced Heart Failure Mouse Model. 
  • Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress. 
  • Genetic association study of QT interval highlights role for calcium signaling pathways in myocardial repolarization. 
  • Genetic changes in human adrenocortical carcinomas. 
  • Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium. 
  • Genome-wide association study of perioperative myocardial infarction after coronary artery bypass surgery. 
  • Genome-wide scan reveals signatures of selection related to pollution adaptation in non-model estuarine Atlantic killifish (Fundulus heteroclitus). 
  • Glipizide stimulates sympathetic outflow in diabetes-prone mice. 
  • Global impact of RNA splicing on transcriptome remodeling in the heart. 
  • Glucocorticoids accelerate the ontogenetic transition of cardiac ventricular myosin heavy-chain isoform expression in the rat: promotion by prenatal exposure to a low dose of dexamethasone. 
  • Glutamine preserves cardiomyocyte viability and enhances recovery of contractile function after ischemia-reperfusion injury. 
  • Glutathione protects cardiac and skeletal muscle from cyclophosphamide-induced toxicity. 
  • Glycogen storage diseases presenting as hypertrophic cardiomyopathy. 
  • Grade III ischemia on presentation with acute myocardial infarction predicts rapid progression of necrosis and less myocardial salvage with thrombolysis. 
  • Growth hormone attenuates early left ventricular remodeling and improves cardiac function in rats with large myocardial infarction. 
  • Guanine nucleotides and alpha 1 adrenergic receptors in the heart. 
  • Guanosine triphosphate binding sites in solubilized myocardium. Relation to adenylate cyclase activity. 
  • H2-DMalpha(-/-) mice show the importance of major histocompatibility complex-bound peptide in cardiac allograft rejection. 
  • Heart fatty acid binding protein as a marker for postmortem detection of early myocardial damage. 
  • Heart rate variability assessment early after acute myocardial infarction. Pathophysiological and prognostic correlates. GUSTO ECG Substudy Investigators. Global Utilization of Streptokinase and TPA for Occluded Arteries. 
  • Heart regeneration in zebrafish. 
  • Heart size-independent analysis of myocardial function in murine pressure overload hypertrophy. 
  • Heart transplantation for a patient with Kearns-Sayre syndrome and end-stage heart failure. 
  • Heart transplantation in neonates and in children. 
  • Heat shock proteins and ischemic injury to the myocardium. 
  • Help for the miffed heart. 
  • Heme oxygenase-1 (HO-1) inhibits postmyocardial infarct remodeling and restores ventricular function. 
  • Heterogeneity of adenylate cyclase-coupled beta-adrenergic receptors. 
  • Hfe deficiency increases susceptibility to cardiotoxicity and exacerbates changes in iron metabolism induced by doxorubicin. 
  • High mortality with severe dystrophic cardiac calcinosis in C3H/OUJ mice fed high fat purified diets. 
  • High-Throughput Tissue Bioenergetics Analysis Reveals Identical Metabolic Allometric Scaling for Teleost Hearts and Whole Organisms. 
  • High-efficiency, long-term cardiac expression of foreign genes in living mouse embryos and neonates. 
  • High-level production of recombinant human lysosomal acid alpha-glucosidase in Chinese hamster ovary cells which targets to heart muscle and corrects glycogen accumulation in fibroblasts from patients with Pompe disease. 
  • High-sensitivity troponin assays: evidence, indications, and reasonable use. 
  • Histologic and biochemical correlates of left ventricular chamber dynamics in man. 
  • Histologic and electron microscopy findings in myocardium of treated Fabry disease. 
  • Hormonal and hemodynamic changes in a validated animal model of brain death. 
  • Human cardiac beta-adrenergic receptors: subtype heterogeneity delineated by direct radioligand binding. 
  • Human cardiac cis-regulatory elements, their cognate transcription factors, and regulatory DNA sequence variants. 
  • Human pathologic correlation with PET in ischemic and nonischemic cardiomyopathy. 
  • Hybrid transgenic mice reveal in vivo specificity of G protein-coupled receptor kinases in the heart. 
  • Hyperoxia-induced tissue hypoxia: a danger? 
  • Hypertrophic Cardiomyopathy: New Evidence Since the 2011 American Cardiology of Cardiology Foundation and American Heart Association Guideline. 
  • Hypertrophic cardiomyopathy in cardiac myosin binding protein-C knockout mice. 
  • Hypertrophy, fibrosis and diastolic dysfunction in early canine experimental hypertension. 
  • Hypoxia reprograms calcium signaling and regulates myoglobin expression. 
  • Hypoxic cell death is reduced by pH buffering in a model of engineered heart tissue. 
  • Identification of cardiac beta-adrenergic receptors by (minus) [3H]alprenolol binding. 
  • Identification of the cardiac beta-adrenergic receptor protein: solubilization and purification by affinity chromatography. 
  • Identification of two calcium channel receptor sites for [3H]nitrendipine in mammalian cardiac and smooth muscle membrane. 
  • Imaging and Impact of Myocardial Strain in Myocarditis. 
  • Imaging methods for morphological and functional phenotyping of the rodent heart. 
  • Imaging of the human heart after administration of L-(N-13)glutamate. 
  • Imbalance between xanthine oxidase and nitric oxide synthase signaling pathways underlies mechanoenergetic uncoupling in the failing heart. 
  • Imbalances emerge in cardiac autonomic cell signaling after neonatal exposure to terbutaline or chlorpyrifos, alone or in combination. 
  • Impact of diabetes on epidemiology, treatment, and outcomes of patients with heart failure. 
  • Impact of serial troponin release on outcomes in patients with acute heart failure: analysis from the PROTECT pilot study. 
  • Impact of time to treatment on myocardial reperfusion and infarct size with primary percutaneous coronary intervention for acute myocardial infarction (from the EMERALD Trial). 
  • Implications of elevated cardiac troponin T in ambulatory patients with heart failure: a prospective analysis. 
  • Importance of an intact growth hormone/insulin-like growth factor 1 axis for normal post-infarction healing: studies in dwarf rats. 
  • Importance of early and complete reperfusion to achieve myocardial salvage after thrombolysis in acute myocardial infarction. 
  • Improved efficacy of gene therapy approaches for Pompe disease using a new, immune-deficient GSD-II mouse model. 
  • Improved tolerance to ischemia in hypertrophied myocardium by preischemic enhancement of adenosine triphosphate. 
  • Improvements to the differential display method for gene analysis. 
  • In cardiomyocyte hypoxia, insulin-like growth factor-I-induced antiapoptotic signaling requires phosphatidylinositol-3-OH-kinase-dependent and mitogen-activated protein kinase-dependent activation of the transcription factor cAMP response element-binding protein. 
  • In vitro monitoring of the dynamic elasticity changes during radiofrequency ablation with acoustic radiation force impulse imaging. 
  • In vivo assessment of LV mass in mice using high-frequency cardiac ultrasound: necropsy validation. 
  • In vivo assessment of left ventricular remodelling after myocardial infarction by digital video contrast angiography in the rat. 
  • In vivo transfer of GPI-linked complement restriction factors from erythrocytes to the endothelium. 
  • Inactivation of the Glucose-Dependent Insulinotropic Polypeptide Receptor Improves Outcomes following Experimental Myocardial Infarction. 
  • Incidence and clinical significance of cardiac biomarker elevation during stem cell mobilization, apheresis, and intramyocardial delivery: an analysis from ACT34-CMI. 
  • Increased expression of Gi-coupled muscarinic acetylcholine receptor and Gi in atrium of elderly diabetic subjects. 
  • Increased ketone body oxidation provides additional energy for the failing heart without improving cardiac efficiency. 
  • Increased lipofuscin on endomyocardial biopsy predicts greater cardiac improvement in adolescents and young adults. 
  • Increased myocardial contractility and enhanced exercise function in transgenic mice overexpressing either adenylyl cyclase 5 or 8. 
  • Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility, and relaxation. 
  • Independent requirements for Hedgehog signaling by both the anterior heart field and neural crest cells for outflow tract development. 
  • Inducible Fgf13 ablation enhances caveolae-mediated cardioprotection during cardiac pressure overload. 
  • Inducible nitric oxide synthase promotes cytokine expression in cardiac allografts but is not required for efficient rejection. 
  • Induction of SENP1 in myocardium contributes to abnormities of mitochondria and cardiomyopathy. 
  • Induction of immediate-early genes by angiotensin II and endothelin-1 in adult rat cardiomyocytes. 
  • Infarct Size, Shock, and Heart Failure: Does Reperfusion Strategy Matter in Early Presenting Patients With ST-Segment Elevation Myocardial Infarction? 
  • Infarct healing is a dynamic process following acute myocardial infarction. 
  • Infarct resorption, compensatory hypertrophy, and differing patterns of ventricular remodeling following myocardial infarctions of varying size. 
  • Influence of dynamic gap junction resistance on impulse propagation in ventricular myocardium: a computer simulation study. 
  • Inhibition of Dipeptidyl Peptidase-4 Impairs Ventricular Function and Promotes Cardiac Fibrosis in High Fat-Fed Diabetic Mice. 
  • Inhibition of cardiac Na+ currents by isoproterenol. 
  • Inhibition of renin-like activity in marmoset tissues by the renin inhibitor CGP 29 287. 
  • Inhibition of sarco(endo)plasmic reticulum Ca2+-ATPase differentially regulates contractile function in cardiac myocytes from normotensive and spontaneously hypertensive rats: role of Ca2+ regulatory proteins. 
  • Inhibition of spontaneous beta 2-adrenergic activation rescues beta 1-adrenergic contractile response in cardiomyocytes overexpressing beta 2-adrenoceptor. 
  • Inhibitor-kappaB kinase-beta regulates LPS-induced TNF-alpha production in cardiac myocytes through modulation of NF-kappaB p65 subunit phosphorylation. 
  • Inhibitory effect of angiotensin II type 2 receptor on coronary arterial remodeling after aortic banding in mice. 
  • Inhibitory effects of anthracenedione antineoplastic agents on hepatic and cardiac lipid peroxidation. 
  • Insulin-stimulated cardiac glucose oxidation is increased in high-fat diet-induced obese mice lacking malonyl CoA decarboxylase. 
  • Interaction of reduced nicotinamide adenine dinucleotide with beef heart s-malate dehydrogenase. 
  • Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction. 
  • Intimal alterations in rat aorta induced by stressful stimuli. 
  • Intracardiac acoustic radiation force impulse imaging: a novel imaging method for intraprocedural evaluation of radiofrequency ablation lesions. 
  • Intracardiac transplantation of a mixed population of bone marrow cells improves both regional systolic contractility and diastolic relaxation. 
  • Intracardiac transplantation of skeletal myoblasts yields two populations of striated cells in situ. 
  • Intracoronary adenovirus-mediated delivery and overexpression of the beta(2)-adrenergic receptor in the heart : prospects for molecular ventricular assistance. 
  • Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. 
  • Intramyocardial Injection of Mesenchymal Precursor Cells and Successful Temporary Weaning From Left Ventricular Assist Device Support in Patients With Advanced Heart Failure: A Randomized Clinical Trial. 
  • Intramyocardial air causes right ventricular dysfunction after repair of a congenital heart defect. 
  • Intramyocardial, autologous CD34+ cell therapy for refractory angina. 
  • Intrapleural administration of AAV9 improves neural and cardiorespiratory function in Pompe disease. 
  • Intravenous allopurinol decreases myocardial oxygen consumption and increases mechanical efficiency in dogs with pacing-induced heart failure. 
  • Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial. 
  • Intrinsic cardiac muscle function, calcium handling and beta -adrenergic responsiveness is impaired in rats with growth hormone deficiency. 
  • Intrinsic myocyte dysfunction and tyrosine kinase pathway activation underlie the impaired wall thickening of adjacent regions during postinfarct left ventricular remodeling. 
  • Invasiveness of human glioma cell lines in vitro: relation to tumorigenicity in athymic mice. 
  • Iodopyridine-for-iodobenzene substitution for use with low molecular weight radiopharmaceuticals: application to m-iodobenzylguanidine. 
  • Ion channels under the sun. 
  • Is chronically dysfunctional yet viable myocardium distal to a severe coronary stenosis hypoperfused? 
  • Islet α cells and glucagon--critical regulators of energy homeostasis. 
  • Isoflurane, but not halothane, induces protection of human myocardium via adenosine A1 receptors and adenosine triphosphate-sensitive potassium channels. 
  • Isoforms of alpha-actinin from cardiac, smooth, and skeletal muscle form polar arrays of actin filaments. 
  • Isolated beta-adrenergic binding sites: a potential assay vehicle for catecholamines. 
  • Isorenin in dog brain and other tissues. 
  • JNK1 is required to preserve cardiac function in the early response to pressure overload. 
  • Lack of Relationship Between Serum Cardiac Troponin I Level and Giant Cell Myocarditis Diagnosis and Outcomes. 
  • Lack of Thy1 defines a pathogenic fraction of cardiac fibroblasts in heart failure. 
  • Lamellar junctional sarcoplasmic reticulum. A specialization of cardiac sarcoplasmic reticulum. 
  • Laser-scanning velocimetry: a confocal microscopy method for quantitative measurement of cardiovascular performance in zebrafish embryos and larvae. 
  • Late Gadolinium Enhancement Cardiac Magnetic Resonance Tissue Characterization for Cancer-Associated Cardiac Masses: Metabolic and Prognostic Manifestations in Relation to Whole-Body Positron Emission Tomography. 
  • Later life swimming performance and persistent heart damage following subteratogenic PAH mixture exposure in the Atlantic killifish (Fundulus heteroclitus). 
  • Lateral MI Explains the Presence of Prominent R Wave (R ≥ S) in V1. 
  • Left ventricular assist device effects on metabolic substrates in the failing heart. 
  • Left ventricular myocardial blood flow, metabolism, and effects of treatment with enalapril: further insights into the mechanisms of canine experimental pacing-induced heart failure. 
  • Less Is More in Post Pediatric Heart Transplant Care. 
  • Lethal Cardiomyopathy in Mice Lacking Transferrin Receptor in the Heart. 
  • Level of beta-adrenergic receptor kinase 1 inhibition determines degree of cardiac dysfunction after chronic pressure overload-induced heart failure. 
  • Lidocaine blockade of continuously and transiently accessible sites in cardiac sodium channels. 
  • Life without myoglobin. 
  • Life-threatening congestive heart failure as the presentation of centronuclear myopathy. 
  • Life-threatening dysrhythmias in varicella myocarditis. 
  • Light-sheet fluorescence imaging to localize cardiac lineage and protein distribution. 
  • Linear relationship between the distribution of thallium-201 and blood flow in ischemic and nonischemic myocardium during exercise. 
  • Lipid metabolism in hypervitaminosis A. 
  • Lipid specificity of beta-hydroxybutyrate dehydrogenase activation. 
  • Loading effect of fibroblast-myocyte coupling on resting potential, impulse propagation, and repolarization: insights from a microstructure model. 
  • Local contractile and growth modulators in the myocardium. 
  • Localization of mRNA for three distinct alpha 1-adrenergic receptor subtypes in human tissues: implications for human alpha-adrenergic physiology. 
  • Long QT syndrome, Brugada syndrome, and conduction system disease are linked to a single sodium channel mutation. 
  • Long-term contractile activity and thyroid hormone supplementation produce engineered rat myocardium with adult-like structure and function. 
  • Long-term correction of glycogen storage disease type II with a hybrid Ad-AAV vector. 
  • Long-term efficacy after [E1-, polymerase-] adenovirus-mediated transfer of human acid-alpha-glucosidase gene into glycogen storage disease type II knockout mice. 
  • Long-term in vivo imaging of multiple organs at the single cell level. 
  • Loss of neonatal hypoxia tolerance after prenatal nicotine exposure: implications for sudden infant death syndrome. 
  • Loss of sarcomeric proteins via upregulation of JAK/STAT signaling underlies interferon-γ-induced contractile deficit in engineered human myocardium. 
  • Low expression of alpha-adrenergic receptors in the aging human heart. 
  • Low lead one ratio predicts clinical outcomes in left bundle branch block. 
  • Low-dose dobutamine tissue-tagged magnetic resonance imaging with 3-dimensional strain analysis allows assessment of myocardial viability in patients with ischemic cardiomyopathy. 
  • Lung, heart, kidney and spleen lipids in experimental tuberculosis in chicken. 
  • Lymphocyte levels of GRK2 (betaARK1) mirror changes in the LVAD-supported failing human heart: lower GRK2 associated with improved beta-adrenergic signaling after mechanical unloading. 
  • Lymphocyte xenoantigens recognized by preformed antibodies. 
  • MED13-dependent signaling from the heart confers leanness by enhancing metabolism in adipose tissue and liver. 
  • MR imaging of myocardial perfusion and viability. 
  • Macrophages and cardiac fibroblasts are the main producers of eotaxins and regulate eosinophil trafficking to the heart. 
  • Magnetic resonance imaging of chronic myocardial infarcts in formalin-fixed human autopsy hearts. 
  • Magnetic resonance myocardial fiber-orientation mapping with direct histological correlation. 
  • Mammalian beta-adrenergic receptors. Structural differences in beta 1 and beta 2 subtypes revealed by peptide maps. 
  • Mapping the Structural Determinants Required for AAVrh.10 Transport across the Blood-Brain Barrier. 
  • Marked enhancement in myocardial function resulting from overexpression of a human beta-adrenergic receptor gene. 
  • Matrix metalloproteinases in patients with myocardial infarction and percutaneous revascularization. 
  • Maturation of sympathetic neurotransmission in the rat heart. IX. Development of transsynaptic regulation of cardiac adrenergic sensitivity. 
  • Measurement of angiotensin II: use of two injectors to minimize HPLC shadowing. 
  • Measuring myocardial scar by CMR. 
  • Measuring the link between cardiac mechanical function and metabolism during hyperpolarized ¹³ C-pyruvate magnetic resonance experiments. 
  • Mechanical and chemical unfolding of a single protein: a comparison. 
  • Mechanical determinants of myocardial oxygen consumption in conscious dogs. 
  • Mechanical unfolding intermediates in titin modules. 
  • Mechanical unloading promotes myocardial energy recovery in human heart failure. 
  • Mechanism of defective oxygen extraction following global ischemia. 
  • Mechanisms of accumulation of arachidonic acid in cultured myocardial cells during ATP depletion. 
  • Mechanisms of action of antiarrhythmic drugs: from ion channel blockage to arrhythmia termination. 
  • Mechanisms of closure of cardiac sodium channels in rabbit ventricular myocytes: single-channel analysis. 
  • Mechanisms of use-dependent block of sodium channels in excitable membranes by local anesthetics. 
  • Mechanotransduction Mechanisms for Intraventricular Diastolic Vortex Forces and Myocardial Deformations: Part 2. 
  • MerTK Cleavage on Resident Cardiac Macrophages Compromises Repair After Myocardial Ischemia Reperfusion Injury. 
  • Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. 
  • Mesenchymal stem cells use integrin beta1 not CXC chemokine receptor 4 for myocardial migration and engraftment. 
  • Metabolic Dysfunction in Heart Failure: Diagnostic, Prognostic, and Pathophysiologic Insights From Metabolomic Profiling. 
  • Metabolic changes in the normal and hypoxic neonatal myocardium. 
  • Metabolic deterioration during global ischemia as a function of time in the intact normal dog heart. 
  • Metabolism and vascular fatty acid transport. 
  • Metabolism of preconditioned myocardium: effect of loss and reinstatement of cardioprotection. 
  • Metabolomic profiling reveals distinct patterns of myocardial substrate use in humans with coronary artery disease or left ventricular dysfunction during surgical ischemia/reperfusion. 
  • Metabolomics-assisted proteomics identifies succinylation and SIRT5 as important regulators of cardiac function. 
  • Metastatic melanoma to the heart. 
  • Methodologies for Inducing Cardiac Injury and Assaying Regeneration in Adult Zebrafish. 
  • Methods for the detection of altered beta-adrenergic receptor signaling pathways in hypertrophied hearts. 
  • Metoprolol and coronary artery bypass grafting surgery: does intraoperative metoprolol attenuate acute beta-adrenergic receptor desensitization during cardiac surgery? 
  • Mice with duplications and deletions at the Tme locus have altered MnSOD activity. 
  • MicroRNAs targeting the SARS-CoV-2 entry receptor ACE2 in cardiomyocytes. 
  • Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure. 
  • Microprobe analysis of Tc-MIBI in heart cells: calculation of mitochondrial membrane potential. 
  • Microvascular integrity and the time course of myocardial sodium accumulation after acute infarction. 
  • MinK-dependent internalization of the IKs potassium channel. 
  • Minor myocardial damage and prognosis: are spontaneous and percutaneous coronary intervention-related events different? 
  • Mitochondrial Creatine Kinase Attenuates Pathologic Remodeling in Heart Failure. 
  • Mitochondrial localization and characterization of 99Tc-SESTAMIBI in heart cells by electron probe X-ray microanalysis and 99Tc-NMR spectroscopy. 
  • Mitochondrial toxicity in hearts of CD-1 mice following perinatal exposure to AZT, 3TC, or AZT/3TC in combination. 
  • Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale. 
  • Mitogen-activated protein kinases in heart development and diseases. 
  • Mitoxantrone: propensity for free radical formation and lipid peroxidation--implications for cardiotoxicity. 
  • Modelling the periodicity of cardiac muscle. 
  • Moderate heart dysfunction in mice with inducible cardiomyocyte-specific excision of the Serca2 gene. 
  • Modifications of the cardiac double-layer source arising from interstitial potentials. 
  • Modified INOvent for delivery of inhaled nitric oxide during cardiac MRI. 
  • Modulation of cytokine-induced cardiac myocyte apoptosis by nitric oxide, Bak, and Bcl-x. 
  • Molecular analysis of the AGL gene: identification of 25 novel mutations and evidence of genetic heterogeneity in patients with Glycogen Storage Disease Type III. 
  • Molecular and functional mechanisms of right ventricular adaptation in chronic pulmonary hypertension. 
  • Molecular and functional signature of heart hypertrophy during pregnancy. 
  • Molecular and physiological aspects of tissue renin-angiotensin system: emphasis on cardiovascular control. 
  • Molecular cloning of acid alpha-glucosidase cDNA of Japanese quail (Coturnix coturnix japonica) and the lack of its mRNA in acid maltase deficient quails. 
  • Molecular imaging: T2-weighted CMR of the area at risk--a risky business? 
  • Molecular species of phosphatidyl choline and phosphatidyl ethanolamine in heart of rats given excess vitamin A. 
  • Monitoring of the electrical status of the ventricle during cardioplegic arrest. 
  • Monoclonal antibodies reveal receptor specificity among G-protein-coupled receptor kinases. 
  • Monocytes prime autoreactive T cells after myocardial infarction. 
  • Mouse cardiac acyl coenzyme a synthetase 1 deficiency impairs Fatty Acid oxidation and induces cardiac hypertrophy. 
  • MuRF2 regulates PPARγ1 activity to protect against diabetic cardiomyopathy and enhance weight gain induced by a high fat diet. 
  • Multicolor mapping of the cardiomyocyte proliferation dynamics that construct the atrium. 
  • Multiple mass isotopomer tracing of acetyl-CoA metabolism in Langendorff-perfused rat hearts: channeling of acetyl-CoA from pyruvate dehydrogenase to carnitine acetyltransferase. 
  • Multiple polyamine regulatory pathways control compensatory cardiovascular hypertrophy in coarctation hypertension. 
  • Multiple-analyte fluoroimmunoassay using an integrated optical waveguide sensor. 
  • Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I. 
  • Mutational fingerprints of aging. 
  • Myeloid Neoplasms Following Solid Organ Transplantation: Clinicopathologic Studies of 23 Cases. 
  • Myocardial Contractile Mechanics in Ischemic Mitral Regurgitation: Multicenter Data Using Stress Perfusion Cardiovascular Magnetic Resonance. 
  • Myocardial Damage Detected by Late Gadolinium Enhancement Cardiac Magnetic Resonance Is Uncommon in Peripartum Cardiomyopathy. 
  • Myocardial Energetics in Heart Failure With Preserved Ejection Fraction. 
  • Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy: A Randomized Clinical Trial. 
  • Myocardial G protein-coupled receptor kinases: implications for heart failure therapy. 
  • Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. 
  • Myocardial Injury Caused by Chronic Alcohol Exposure-A Pilot Study Based on Proteomics. 
  • Myocardial Involvement in Patients With Histologically Diagnosed Cardiac Sarcoidosis: A Systematic Review and Meta-Analysis of Gross Pathological Images From Autopsy or Cardiac Transplantation Cases. 
  • Myocardial Lipin 1 knockout in mice approximates cardiac effects of human LPIN1 mutations. 
  • Myocardial NF-κB activation is essential for zebrafish heart regeneration. 
  • Myocardial Na+/H+ exchanger-1 (NHE1) content is decreased by exercise training. 
  • Myocardial adenosine triphosphate levels during early sepsis. 
  • Myocardial beta-adrenergic receptor function and high-energy phosphates in brain death--related cardiac dysfunction. 
  • Myocardial beta-adrenergic receptor signaling in vivo: insights from transgenic mice. 
  • Myocardial beta-adrenergic receptors from adrenalectomized rats: impaired formation of high-affinity agonist-receptor complexes. 
  • Myocardial blood flow and oxygen consumption in the empty-beating, fibrillating, and potassium-arrested hypertrophied canine heart. 
  • Myocardial cell hypertrophy after myocardial infarction with reperfusion in dogs. 
  • Myocardial distribution of cardioplegic solution after retrograde delivery in patients undergoing cardiac surgical procedures. 
  • Myocardial energetics and blood flow in acute rapid ventricular pacing. 
  • Myocardial expression of a constitutively active alpha 1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy. 
  • Myocardial fiber orientation mapping using reduced encoding diffusion tensor imaging. 
  • Myocardial fibrosis in endomyocardial biopsy specimens: do different bioptomes affect estimation? 
  • Myocardial function in hearts with transgenic overexpression of the G protein-coupled receptor kinase 5. 
  • Myocardial guanylate cyclase: properties of the enzyme and effects of cholinergic agonists in vitro. 
  • Myocardial hibernation and stunning: still much to learn. 
  • Myocardial hypertrophy in the ischemic zone induced by exercise in rats after coronary reperfusion. 
  • Myocardial injury and ventricular dysfunction related to training levels among nonelite participants in the Boston marathon. 
  • Myocardial injury-induced fibroblast proliferation facilitates retroviral-mediated gene transfer to the rat heart in vivo. 
  • Myocardial involvement in Rocky Mountain spotted fever. 
  • Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury. 
  • Myocardial myoglobin deficiency in various animal models of congestive heart failure. 
  • Myocardial overexpression of GRK3 in transgenic mice: evidence for in vivo selectivity of GRKs. 
  • Myocardial overexpression of adrenergic receptors and receptor kinases. 
  • Myocardial oxygenation in dogs during partial and complete coronary artery occlusion. 
  • Myocardial recovery after ischemia and reperfusion injury is significantly impaired in hearts with transgenic overexpression of beta-adrenergic receptor kinase. 
  • Myocardial remodelling and matrix metalloproteinases in heart failure: turmoil within the interstitium. 
  • Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. 
  • Myocardial viability and impact of surgical ventricular reconstruction on outcomes of patients with severe left ventricular dysfunction undergoing coronary artery bypass surgery: results of the Surgical Treatment for Ischemic Heart Failure trial. 
  • Myocardial viability and survival in ischemic left ventricular dysfunction. 
  • Myocardial viability in ischemic left ventricular dysfunction. 
  • Myocardial viability mapping by magnetic resonance-based multiparametric systolic strain analysis. 
  • Myocardial volume and organization are changed by failure of addition of secondary heart field myocardium to the cardiac outflow tract. 
  • Myocardin induces cardiomyocyte hypertrophy. 
  • Myocardium and BMP signaling are required for endocardial differentiation. 
  • Myonecrosis after revascularization procedures. 
  • Myonecrosis following stent placement: association between impaired TIMI myocardial perfusion grade and MRI visualization of microinfarction. 
  • Na channel kinetics remain stable during perforated-patch recordings. 
  • Nasal vaccination with troponin reduces troponin specific T-cell responses and improves heart function in myocardial ischemia-reperfusion injury. 
  • Nav1.5 E1053K mutation causing Brugada syndrome blocks binding to ankyrin-G and expression of Nav1.5 on the surface of cardiomyocytes. 
  • Near infrared spectroscopy: in situ studies of skeletal and cardiac muscle. 
  • Neonatal central catecholaminergic lesions with intracisternal 6-hydroxydopamine: effects on development of presynaptic and postsynaptic components of peripheral sympathetic pathways and on the ornithine decarboxylase/polyamine system in heart, lung and kidney. 
  • Neonatal nutritional deprivation or enhancement: the cardiac-sympathetic axis and its role in cardiac growth and stress responses. 
  • Neonatal organophosphorus pesticide exposure alters the developmental trajectory of cell-signaling cascades controlling metabolism: differential effects of diazinon and parathion. 
  • Neonatal parathion exposure and interactions with a high-fat diet in adulthood: Adenylyl cyclase-mediated cell signaling in heart, liver and cerebellum. 
  • Neonatal sympathectomy compromises development of responses of ornithine decarboxylase to hormonal stimulation in peripheral tissues. 
  • Neovascularization after transmyocardial laser revascularization in a model of chronic ischemia. 
  • Network integration of the adrenergic system in cardiac hypertrophy. 
  • Neural input and the development of adrenergic intracellular signaling: neonatal denervation evokes neither receptor upregulation nor persistent supersensitivity of adenylate cyclase. 
  • Neurogenic Stunned Myocardium Following Acute Subarachnoid Hemorrhage: Pathophysiology and Practical Considerations. 
  • Neuronal control of cardiac and hepatic macromolecule synthesis in the neonatal rat: effects of sympathectomy. 
  • Nitric oxide donors protect murine myocardium against infarction via modulation of mitochondrial permeability transition. 
  • Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. 
  • Nitric oxide synthase inhibitors decrease coronary sinus-free radical concentration and ameliorate myocardial stunning in an ischemia-reperfusion model. 
  • Nitroglycerine: relief from the heartache of decompression sickness? 
  • Noncorticosteroid immunosuppression limits myocardial damage and contractile dysfunction in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome). 
  • Nonischemic cardiomyopathy associated with autoimmune polyglandular syndrome type II. 
  • Noradrenaline biosynthesis and metabolism during development and recovery from pacing-induced heart failure in the dog. 
  • Norepinephrine: dissociation of -receptor binding from adenylate cyclase activation in solubilized myocardium. 
  • Normal cardiac function in mice with supraphysiological cardiac creatine levels. 
  • Notch signaling genes: myogenic DNA hypomethylation and 5-hydroxymethylcytosine. 
  • Novel Genetic Triggers and Genotype-Phenotype Correlations in Patients With Left Ventricular Noncompaction. 
  • Novel Methodology for Measuring Regional Myocardial Efficiency. 
  • Novel anisotropic engineered cardiac tissues: studies of electrical propagation. 
  • Novel approach in LC-MS/MS using MRM to generate a full profile of acyl-CoAs: discovery of acyl-dephospho-CoAs. 
  • Nrg1 is an injury-induced cardiomyocyte mitogen for the endogenous heart regeneration program in zebrafish. 
  • Nutritional modulation of heart failure in mitochondrial pyruvate carrier-deficient mice. 
  • Obligatory role of thyroid hormones in development of peripheral sympathetic and central nervous system catecholaminergic neurons: effects of propylthiouracil-induced hypothyroidism on transmitter levels, turnover and release. 
  • Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation. 
  • On the physiological importance of endoproteolysis of CAAX proteins: heart-specific RCE1 knockout mice develop a lethal cardiomyopathy. 
  • Ontogenesis of prolactin receptors in the human fetus in early gestation. Implications for tissue differentiation and development. 
  • Ontogenetic transition of cardiac myosin heavy chain isoforms in rat ventricle: effects of fetal exposure to beta-adrenergic agonists or antagonists. 
  • Ontogeny of G-protein expression: control by beta-adrenoceptors. 
  • Ontogeny of cardiac beta-adrenoceptor desensitization mechanisms: agonist treatment enhances receptor/G-protein transduction rather than eliciting uncoupling. 
  • Ontogeny of food deprivation effects on ornithine decarboxylase: ornithine decarboxylase induction by alpha and beta agonists. 
  • Ontogeny of regulatory mechanisms for beta-adrenoceptor control of rat cardiac adenylyl cyclase: targeting of G-proteins and the cyclase catalytic subunit. 
  • Ontogeny of stress effects on ornithine decarboxylase activity in rats. 
  • Optimizing cardiac MR imaging: practical remedies for artifacts. 
  • Oral Iron Therapy for Heart Failure With Reduced Ejection Fraction: Design and Rationale for Oral Iron Repletion Effects on Oxygen Uptake in Heart Failure. 
  • Ornithine decarboxylase and polyamines in tissues of the neonatal rat: effects of alpha-difluoromethylornithine, a specific, irreversible inhibitor of ornithine decarboxylase. 
  • Ornithine decarboxylase in developing rat heart and brain: role of sympathetic development for responses to autonomic stimulants and the effects of reserpine on maturation. 
  • Orotic acid improves left ventricular recovery four days after heterotopic transplantation. 
  • Ouabain effects on intracellular potassium activity and contractile force in cat papillary muscle. 
  • Outcomes and predictors of recovery in acute-onset cardiomyopathy: A single-center experience of patients undergoing endomyocardial biopsy for new heart failure. 
  • Outcomes following cardioversion for patients with cardiac amyloidosis and atrial fibrillation or atrial flutter. 
  • Overexpression of TNNI3K, a cardiac-specific MAPKKK, promotes cardiac dysfunction. 
  • Overexpression of alpha 2-adrenergic receptors in fetal rat heart: receptors in search of a function. 
  • Overexpression of angiotensin AT1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block. 
  • Overexpression of bone morphogenetic protein 10 in myocardium disrupts cardiac postnatal hypertrophic growth. 
  • Overexpression of the cardiac beta(2)-adrenergic receptor and expression of a beta-adrenergic receptor kinase-1 (betaARK1) inhibitor both increase myocardial contractility but have differential effects on susceptibility to ischemic injury. 
  • Overexpression of the rat sarcoplasmic reticulum Ca2+ ATPase gene in the heart of transgenic mice accelerates calcium transients and cardiac relaxation. 
  • Oxygen sufficiency in working rabbit papillary muscle at 35 degrees C. 
  • PAR1 (Protease-Activated Receptor 1) Pepducin Therapy Targeting Myocardial Necrosis in Coronary Artery Disease and Acute Coronary Syndrome Patients Undergoing Cardiac Catheterization: A Randomized, Placebo-Controlled, Phase 2 Study. 
  • PH-Dependent effects of quinidine on the kinetics of dV/dtmax in guinea pig ventricular myocardium. 
  • Pacing-induced heart failure: a model to study the mechanism of disease progression and novel therapy in heart failure. 
  • Palpitations in a 64-year-old man. 
  • Para-[18F]fluorobenzylguanidine kinetics in a canine coronary artery occlusion model. 
  • Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. 
  • Passive ventricular mechanics in tight-skin mice. 
  • Pathogenic Potential of Hic1-Expressing Cardiac Stromal Progenitors. 
  • Pathologic findings following sudden death in an infant with hypertrophic cardiomyopathy and supraventricular tachycardia. 
  • Peptide hormone "receptors": specific binding of 3 H-FSH to testis. 
  • Perfluorocarbon administration during cardiopulmonary bypass in rats: an inflammatory link to adverse outcome? 
  • Pericardial delivery of omega-3 fatty acid: a novel approach to reducing myocardial infarct sizes and arrhythmias. 
  • Perinatal exposure to environmental tobacco smoke alters cell signaling in a primate model: autonomic receptors and the control of adenylyl cyclase activity in heart and lung. 
  • Perturbed length-dependent activation in human hypertrophic cardiomyopathy with missense sarcomeric gene mutations. 
  • Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary Intervention: a delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial. 
  • Pharmacodynamics of basic fibroblast growth factor: route of administration determines myocardial and systemic distribution. 
  • Phase III evaluation of doxorubicin and whole-body hyperthermia in dogs with lymphoma. 
  • Phenylephrine induces delayed cardioprotection against necrosis without amelioration of stunning. 
  • Phosphoproteome analysis reveals regulatory sites in major pathways of cardiac mitochondria. 
  • Phosphoproteomic profiling of human myocardial tissues distinguishes ischemic from non-ischemic end stage heart failure. 
  • Phosphorylation of chick heart muscarinic cholinergic receptors by the beta-adrenergic receptor kinase. 
  • Phosphorylation of the cardiac muscarinic receptor in intact chick heart and its regulation by a muscarinic agonist. 
  • Phosphorylation specificities of protein kinase C isozymes for bovine cardiac troponin I and troponin T and sites within these proteins and regulation of myofilament properties. 
  • Physical conditioning and membrane receptors for cardioregulatory hormones. 
  • Physiologic and cardiac roles of beta-arrestins. 
  • Physiological assessment of complex cardiac phenotypes in genetically engineered mice. 
  • Physiological basis for potassium (39K) magnetic resonance imaging of the heart. 
  • Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. 
  • Physiological effects of inverse agonists in transgenic mice with myocardial overexpression of the beta 2-adrenoceptor. 
  • Physiological impact of increased expression of the AT1 angiotensin receptor. 
  • Physiological induction of a beta-adrenergic receptor kinase inhibitor transgene preserves ss-adrenergic responsiveness in pressure-overload cardiac hypertrophy. 
  • Physiological receptors as physicochemical entities. 
  • Plasma and cardiac tissue atrial and brain natriuretic peptides in experimental heart failure. 
  • Platelet inhibition to target reperfusion injury trial: Rationale and study design. 
  • Pluripotent stem cell-derived cardiac tissue patch with advanced structure and function. 
  • Point mutations alter the mechanical stability of immunoglobulin modules. 
  • Polyamines in brain and heart of the neonatal rat: effects of inhibitors of ornithine decarboxylase and spermidine synthase. 
  • Post-translational regulation of calsarcin-1 during pressure overload-induced cardiac hypertrophy. 
  • Postnatal distribution of vitamin A in liver, lung, heart and brain of the rat in relation to maternal vitamin A status. 
  • Potassium channel blockade amplifies cardiac instability numerical studies of torsades de pointes. 
  • Potential for germ line transmission after intramyocardial gene delivery by adeno-associated virus. 
  • Pre-emptive gene therapy using recombinant adeno-associated virus delivery of extracellular superoxide dismutase protects heart against ischemic reperfusion injury, improves ventricular function and prolongs survival. 
  • Prediction of enzymatic infarct size in ST-segment elevation myocardial infarction. 
  • Premature development of cardiac sympathetic neurotransmission in the fetal alcohol syndrome. 
  • Presence of mechanical dyssynchrony in Duchenne muscular dystrophy. 
  • Preservation of myocardial beta-adrenergic receptor signaling delays the development of heart failure after myocardial infarction. 
  • Preservation of myocardial high energy phosphates during cardioplegic arrest with nifedipine. 
  • Preservation of myocardial high-energy phosphates with vagal stimulation and hypothermic cardioplegia. 
  • Preserved heart function and maintained response to cardiac stresses in a genetic model of cardiomyocyte-targeted deficiency of cyclooxygenase-2. 
  • Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice. 
  • Pressure-mediated oligonucleotide transfection of rat and human cardiovascular tissues. 
  • Pretranslational regulation of myoglobin gene expression. 
  • Prevalence and distribution of late gadolinium enhancement in a large population of patients with Duchenne muscular dystrophy: effect of age and left ventricular systolic function. 
  • Primary neonatal hyperparathyroidism--an unusual cause of failure to thrive. 
  • Prinzmetal's angina, normal coronary arteries and pericarditis. 
  • Probucol prevents early coronary heart disease and death in the high-density lipoprotein receptor SR-BI/apolipoprotein E double knockout mouse. 
  • Progesterone receptors in the human heart and great vessels. 
  • Prognostic Value of Myocardial Damage in Patients With Sarcoidosis: Is Cardiac Magnetic Resonance What We Need? 
  • Prognostic estimation of coronary artery disease risk with resting perfusion abnormalities and stress ischemia on myocardial perfusion SPECT. 
  • Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease. 
  • Prognostic validation of an algorithm to convert myocardial perfusion SPECT imaging data from a 12-segment model to a 17-segment model. 
  • Prognostic value of left ventricular apical tissue removed for HeartMate II left ventricular assist device placement. 
  • Prognostic value of routine cardiac magnetic resonance assessment of left ventricular ejection fraction and myocardial damage: an international, multicenter study. 
  • Progressive cardiac dysfunction and fibrosis in the cardiomyopathic hamster and effects of growth hormone and angiotensin-converting enzyme inhibition. 
  • Proinflammatory effects of interferon gamma in mouse adenovirus 1 myocarditis. 
  • Prolonged discordant cardiac xenograft survival in newborn recipients. 
  • Prolonged discordant xenograft survival and delayed xenograft rejection in a pig-to-baboon orthotopic cardiac xenograft model. 
  • Prolonged exercise alters beta-adrenergic responsiveness in healthy sedentary humans. 
  • Prolonged heart xenograft survival using combined total lymphoid irradiation and cyclosporine. 
  • Prolonged survival of class II transactivator-deficient cardiac allografts. 
  • Promotional role for glucocorticoids in the development of intracellular signalling: enhanced cardiac and renal adenylate cyclase reactivity to beta-adrenergic and non-adrenergic stimuli after low-dose fetal dexamethasone exposure. 
  • Promotional role for glucocorticoids in the development of intracellular signalling: enhanced cardiac and renal adenylate cyclase reactivity to beta-adrenergic and non-adrenergic stimuli after low-dose fetal dexamethasone exposure. 
  • Propionate-induced changes in cardiac metabolism, notably CoA trapping, are not altered by l-carnitine. 
  • Prospective analysis of possible myocardial damage or hemolysis occurring as a result of prolonged autoperfusion angioplasty in humans. 
  • Prostacyclin protects against elevated blood pressure and cardiac fibrosis. 
  • Protein kinetic signatures of the remodeling heart following isoproterenol stimulation. 
  • Protein turnover in the failing heart: an ever-changing landscape. 
  • Proteolytic cleavage and PKA phosphorylation of α1C subunit are not required for adrenergic regulation of CaV1.2 in the heart. 
  • Proteomic analysis of cardiac response to thermal acclimation in the eurythermal goby fish Gillichthys mirabilis. 
  • Purification and characterization of a lecithin-D(-)- -hydroxybutyrate dehydrogenase complex. 
  • Quantifiable Biomarkers of Normal Aging in the Japanese Medaka Fish (Oryzias latipes) 
  • Quantification of myocardial perfusion by MRI after coronary occlusion. 
  • Quantitative analysis of the chromatin proteome in disease reveals remodeling principles and identifies high mobility group protein B2 as a regulator of hypertrophic growth. 
  • Quantitative cardiac magnetic resonance T2 imaging offers ability to non-invasively predict acute allograft rejection in children. 
  • Quantitative microchemical imaging of calcium in Na-K pump inhibited heart cells. 
  • Quantitative resolution of beta-adrenergic receptor subtypes by selective ligand binding: application of a computerized model fitting technique. 
  • Quick-freezing of cultured cardiac cells in situ with special attention to the mitochondrial ultrastructure. 
  • Quinidine blocks adenosine 5'-triphosphate-sensitive potassium channels in heart. 
  • Rapid up-regulation of peptide elongation factor EF-1alpha protein levels is an immediate early event during oxidative stress-induced apoptosis. 
  • Rapid ventricular pacing in the dog: pathophysiologic studies of heart failure. 
  • Rapid ventricular pacing of dogs to heart failure: biochemical and physiological studies. 
  • Rationale and design of a randomized controlled trial of allogeneic mesenchymal stem cells in patients with nonischemic cardiomyopathy. 
  • Real-time quantitative elemental analysis and mapping: microchemical imaging in cell physiology. 
  • Real-time three-dimensional intracardiac echocardiography. 
  • Realistic CT simulation using the 4D XCAT phantom. 
  • Receptor crosstalk: effects of prolonged carbachol exposure on beta 1-adrenoceptors and adenylyl cyclase activity in neonatal rat ventricular myocytes. 
  • Receptor-specific in vivo desensitization by the G protein-coupled receptor kinase-5 in transgenic mice. 
  • Reciprocal Regulation of the Cardiac Epigenome by Chromatin Structural Proteins Hmgb and Ctcf: IMPLICATIONS FOR TRANSCRIPTIONAL REGULATION. 
  • Reciprocal in vivo regulation of myocardial G protein-coupled receptor kinase expression by beta-adrenergic receptor stimulation and blockade. 
  • Reciprocal modulation of agonist and antagonist binding to muscarinic cholinergic receptor by guanine nucleotide. 
  • Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I/II clinical trial. 
  • Recurrence of cardiac sarcoidosis in a heart transplant recipient. 
  • Redirecting cardiac growth mechanisms for therapeutic regeneration. 
  • Reduced arsenic clearance and increased toxicity in aquaglyceroporin-9-null mice. 
  • Reduced cardiac selenium content in the acquired immunodeficiency syndrome. 
  • Reduced life span with heart and muscle dysfunction in Drosophila sarcoglycan mutants. 
  • Reduced reperfusion-induced Ins(1,4,5)P3 generation and arrhythmias in hearts expressing constitutively active alpha1B-adrenergic receptors. 
  • Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. 
  • Region specific modeling of cardiac muscle: comparison of simulated and experimental potentials. 
  • Regional absence of mitochondria causing energy depletion in the myocardium of muscle LIM protein knockout mice. 
  • Regional geometry and function during myocardial ischemia and recovery. 
  • Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms. 
  • Regression of cardiac amyloidosis after stem cell transplantation assessed by cardiovascular magnetic resonance imaging. 
  • Regulated addition of new myocardial and epicardial cells fosters homeostatic cardiac growth and maintenance in adult zebrafish. 
  • Regulating the regulator: NF-kappaB signaling in heart. 
  • Regulation of G protein-coupled receptor signaling by scaffold proteins. 
  • Regulation of adrenergic receptor function by phosphorylation. II. Effects of agonist occupancy on phosphorylation of alpha 1- and beta 2-adrenergic receptors by protein kinase C and the cyclic AMP-dependent protein kinase. 
  • Regulation of beta-adrenergic receptor signaling by S-nitrosylation of G-protein-coupled receptor kinase 2. 
  • Regulation of fetal cardiac and hepatic beta-adrenoceptors and adenylyl cyclase signaling: terbutaline effects. 
  • Regulation of myocardial betaARK1 expression in catecholamine-induced cardiac hypertrophy in transgenic mice overexpressing alpha1B-adrenergic receptors. 
  • Regulation of ornithine decarboxylase activity in the developing heart of euthyroid or hyperthyroid rats. 
  • Regulation of rat heart ornithine decarboxylase: change in affinity for ornithine evoked by neuronal, hormonal, and ontogenetic stimuli. 
  • Regulation of receptor function by protein phosphorylation. 
  • Regulatory elements governing transcription in specialized myofiber subtypes. 
  • Rejection of canine cardiac allografts. 
  • Relation between reversal of diastolic creep and recovery of systolic function after ischemic myocardial injury in conscious dogs. 
  • Relationship between structure and sodium channel blockade by lidocaine and its amino-alkyl derivatives. 
  • Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. 
  • Relationship of T2-Weighted MRI Myocardial Hyperintensity and the Ischemic Area-At-Risk. 
  • Relationship of disease-associated gene expression to cardiac phenotype is buffered by genetic diversity and chromatin regulation. 
  • Relationship of elevated 23Na magnetic resonance image intensity to infarct size after acute reperfused myocardial infarction. 
  • Relative expression of aromatase cytochrome P450 in human fetal tissues as determined by competitive polymerase chain reaction amplification. 
  • Relative wall thickness analysis by two-dimensional echocardiography. 
  • Release of arachidonate from membrane phospholipids in cultured neonatal rat myocardial cells during adenosine triphosphate depletion. Correlation with the progression of cell injury. 
  • Remodeling and reparation of the cardiovascular system. 
  • Renal denervation attenuates NADPH oxidase-mediated oxidative stress and hypertension in rats with hydronephrosis. 
  • Reperfusion ventricular arrhythmia bursts identify larger infarct size in spite of optimal epicardial and microvascular reperfusion using cardiac magnetic resonance imaging. 
  • Reply: predicting sudden cardiac death in heart failure. 
  • Research resource: tissue- and pathway-specific metabolomic profiles of the steroid receptor coactivator (SRC) family. 
  • Resistance differences between blood and crystalloid cardioplegic solutions with myocardial cooling. 
  • Resistance to teratogenesis by F1 and F2 embryos of PAH-adapted Fundulus heteroclitus is strongly inherited despite reduced recalcitrance of the AHR pathway. 
  • Respiratory motion and cardiac arrhythmia effects on diagnostic accuracy of myocardial delayed-enhanced MR imaging in canines. 
  • Response of atrial natriuretic factor to acute and chronic increases of atrial pressures in experimental heart failure in dogs. Role of changes in heart rate, atrial dimension, and cardiac tissue concentration. 
  • Response of hypertrophied myocardium to ischemia: correlation with biochemical and physiological parameters. 
  • Responses of heart ornithine decarboxylase and adrenal catecholamines to methadone and sympathetic stimulants in developing and adults rats. 
  • Reverse engineering of the giant muscle protein titin. 
  • Ribose-enhanced myocardial recovery following ischemia in the isolated working rat heart. 
  • Right ventricular adaptation to increased afterload after orthotopic cardiac transplantation in the setting of recipient chronic pulmonary hypertension. 
  • Right ventricular arrhythmia in the absence of arrhythmogenic dysplasia: MR imaging of myocardial abnormalities. 
  • Right ventricular morphology and systolic function in left ventricular noncompaction cardiomyopathy. 
  • Right ventricular pathology in chronic pulmonary hypertension. 
  • Right ventricular sensitivity to metabolic injury during cardiopulmonary bypass. 
  • Rocky Mountain spotted fever in childhood. 
  • Rocky mountain spotted fever in childhood. 
  • Role for thromboxane receptors in angiotensin-II-induced hypertension. 
  • Role of Mitochondrial Oxidative Stress in Glucose Tolerance, Insulin Resistance, and Cardiac Diastolic Dysfunction. 
  • Role of endomyocardial biopsy in rejection surveillance after heart transplantation in neonates and children. 
  • Role of ornithine decarboxylase in cardiac growth and hypertrophy. 
  • Role of receptor mechanisms in the adaptive response to habitual exercise. 
  • Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function. 
  • Role of sympathetic neurons in development of beta-adrenergic control of ornithine decarboxylase activity in peripheral tissues: effects of neonatal 6-hydroxydopamine treatment. 
  • Role of thyroid hormone in the development of beta adrenergic control of ornithine decarboxylase in rat heart and kidney. 
  • Routine performance of endomyocardial biopsy decreases the incidence of orthotopic heart transplant for myocarditis. 
  • SARS-CoV-2 Cardiac Involvement in Young Competitive Athletes. 
  • SHP-2 is required for the maintenance of cardiac progenitors. 
  • SOCE and STIM1 signaling in the heart: Timing and location matter. 
  • SRC-2 coactivator deficiency decreases functional reserve in response to pressure overload of mouse heart. 
  • Salmeterol enhances the cardiac response to gene therapy in Pompe disease. 
  • Sarcoplasmic reticulum calcium defect in Ras-induced hypertrophic cardiomyopathy heart. 
  • Secondary heart field contributes myocardium and smooth muscle to the arterial pole of the developing heart. 
  • Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair. 
  • Segment Length in Cine Strain Analysis Predicts Cardiac Resynchronization Therapy Outcome Beyond Current Guidelines. 
  • Selective loss of ornithine decarboxylase response to adrenergic agonists and glucagon during food deprivation of neonatal rats. 
  • Selective phosphorylation of PKA targets after β-adrenergic receptor stimulation impairs myofilament function in Mybpc3-targeted HCM mouse model. 
  • Selectivity of dobutamine for adrenergic receptor subtypes: in vitro analysis by radioligand binding. 
  • Semiquantitative measurement of cytokine messenger RNA in endomyocardium and peripheral blood mononuclear cells from human heart transplant recipients. 
  • Sensing heart stress. 
  • Sequential echocardiographic-Doppler assessment of left ventricular remodelling and mitral regurgitation during evolving experimental heart failure. 
  • Serial changes of natural antithrombotics during myocardial ischemia-reperfusion in swine. Effects of magnesium, diltiazem, and a novel Mac-1 inhibitor. 
  • Severity of Remodeling, Myocardial Viability, and Survival in Ischemic LV Dysfunction After Surgical Revascularization. 
  • Simulation of use-dependent uptake of ion channel blocking agents by excitable membranes. 
  • Single dose of glutamine enhances myocardial tissue metabolism, glutathione content, and improves myocardial function after ischemia-reperfusion injury. 
  • Single protein misfolding events captured by atomic force microscopy. 
  • Single-cell analysis uncovers that metabolic reprogramming by ErbB2 signaling is essential for cardiomyocyte proliferation in the regenerating heart. 
  • Size of Anterior Wall Acute Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention in United States Versus Europe/Australia Versus India (from the CRISP-AMI Randomized Controlled Trial). 
  • Skeletal muscle grafts applied to the heart. A word of caution. 
  • Smad3 Signaling Promotes Fibrosis While Preserving Cardiac and Aortic Geometry in Obese Diabetic Mice. 
  • Sonomicrometric determination of ischemic contracture of the left ventricle. 
  • Sources of variability in quantification of cardiovascular magnetic resonance infarct size - reproducibility among three core laboratories. 
  • Sparseness prior based iterative image reconstruction for retrospectively gated cardiac micro-CT. 
  • Species specificity of antibodies to regulatory subunits of cyclic AMP-dependent protein kinases. 
  • Species variability in angiotensin receptor expression by cultured cardiac fibroblasts and the infarcted heart. 
  • Specific and non-specific measurements of tissue angiotensin II cascade members. 
  • Specific binding of -adrenergic catecholamines to a subcellular fraction from cardiac muscle. 
  • Spectrum of humoral rejection after pediatric heart transplantation. 
  • Stability of the beta-adrenergic receptor/adenylyl cyclase pathway of pediatric myocardium after brain death. 
  • Starch Binding Domain-containing Protein 1 Plays a Dominant Role in Glycogen Transport to Lysosomes in Liver. 
  • Steady state kinetics of soluble and membrane-bound mitochondrial ATPase. 
  • Stimulation of long-chain fatty acid uptake by dipyridamole in isolated myocytes. 
  • Stimulation of rat heart ornithine decarboxylase by isoproterenol evidence for post-translational control of enzyme activity? 
  • Structural and elemental characterization of heart cells grown in a collagen matrix. 
  • Structural and functional characterization of the purified cardiac ryanodine receptor-Ca2+ release channel complex. 
  • Structural remodeling of cardiac myocytes in patients with ischemic cardiomyopathy. 
  • Structure of the human gene (COX6A2) for the heart/muscle isoform of cytochrome c oxidase subunit VIa and its chromosomal location in humans, mice, and cattle. 
  • Study of unipolar electrogram morphology in a computer model of atrial fibrillation. 
  • Stunned myocardium in the toxic shock syndrome. 
  • Subsensitivity of adenylate cyclase and decreased beta-adrenergic receptor binding after chronic exposure to (minus)-isoproterenol in vitro. 
  • Substrate specificities of g protein-coupled receptor kinase-2 and -3 at cardiac myocyte receptors provide basis for distinct roles in regulation of myocardial function. 
  • Subtype specificity of alpha-adrenergic receptors in rat heart. 
  • Surrogate markers for late cardiac allograft survival. 
  • Susceptibility to vascular neoplasms but no increased susceptibility to renal carcinogenesis in Vhl knockout mice. 
  • Synaptic vesicles isolated from rat heart: l-[3H]norepinephrine uptake properties. 
  • Syncoilin isoform organization and differential expression in murine striated muscle. 
  • Systemic arterial expression of matrix metalloproteinases 2 and 9 in acute Kawasaki disease. 
  • Systemic infection by fusarium in a burned child. The emergence of a saprophytic strain. 
  • Systems Genetics Approach Identifies Gene Pathways and Adamts2 as Drivers of Isoproterenol-Induced Cardiac Hypertrophy and Cardiomyopathy in Mice. 
  • T2-weighted imaging to assess post-infarct myocardium at risk. 
  • TASK-1 and TASK-3 channels modulate pressure overload-induced cardiac remodeling and dysfunction. 
  • TBX5 is required for embryonic cardiac cell cycle progression. 
  • TRPC1 channels are critical for hypertrophic signaling in the heart. 
  • Targeted activation of c-Jun N-terminal kinase in vivo induces restrictive cardiomyopathy and conduction defects. 
  • Targeted developmental overexpression of calmodulin induces proliferative and hypertrophic growth of cardiomyocytes in transgenic mice. 
  • Targeted inhibition of calcineurin in pressure-overload cardiac hypertrophy. Preservation of systolic function. 
  • Targeted overexpression of noncleavable and secreted forms of tumor necrosis factor provokes disparate cardiac phenotypes. 
  • Targeted overexpression of phospholamban to mouse atrium depresses Ca2+ transport and contractility. 
  • Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy. 
  • Tbx5 and Tbx20 act synergistically to control vertebrate heart morphogenesis. 
  • Technology insight: MRI of the myocardium. 
  • Technology insight: assessment of myocardial viability by delayed-enhancement magnetic resonance imaging. 
  • Temperature immutability of adenyl cyclase-coupled beta adrenergic receptors. 
  • Temperature-controlled and constant-power radio-frequency ablation: what affects lesion growth? 
  • Temporal activation of c-Jun N-terminal kinase in adult transgenic heart via cre-loxP-mediated DNA recombination. 
  • The AAV vector toolkit: poised at the clinical crossroads. 
  • The Athena trials: Autologous adipose-derived regenerative cells for refractory chronic myocardial ischemia with left ventricular dysfunction. 
  • The CO/HO system reverses inhibition of mitochondrial biogenesis and prevents murine doxorubicin cardiomyopathy. 
  • The Calcineurin-FoxO-MuRF1 signaling pathway regulates myofibril integrity in cardiomyocytes. 
  • The CapZ interacting protein Rcsd1 is required for cardiogenesis downstream of Wnt11a in Xenopus laevis. 
  • The PDZ motif of the α1C subunit is not required for surface trafficking and adrenergic modulation of CaV1.2 channel in the heart. 
  • The ability of the electrocardiogram in left bundle branch block to detect myocardial scar determined by cardiovascular magnetic resonance. 
  • The accuracy of the electrocardiogram during exercise stress test based on heart size. 
  • The ankyrin-B C-terminal domain determines activity of ankyrin-B/G chimeras in rescue of abnormal inositol 1,4,5-trisphosphate and ryanodine receptor distribution in ankyrin-B (-/-) neonatal cardiomyocytes. 
  • The beta-adrenergic receptor in heart failure. 
  • The bone morphogenetic protein antagonist noggin regulates mammalian cardiac morphogenesis. 
  • The cardiac Na+-Ca2+ exchanger binds to the cytoskeletal protein ankyrin. 
  • The cardiac beta-adrenergic receptor. Structural similarities of beta 1 and beta 2 receptor subtypes demonstrated by photoaffinity labeling. 
  • The change in B-type natriuretic peptide levels over time predicts significant rejection in cardiac transplant recipients. 
  • The chromatin-binding protein Smyd1 restricts adult mammalian heart growth. 
  • The conserved phosphoinositide 3-kinase pathway determines heart size in mice. 
  • The deubiquitinase ubiquitin-specific protease 20 is a positive modulator of myocardial β1-adrenergic receptor expression and signaling. 
  • The effect of cyclosporine, total lymphoid irradiation, and cobra venom factor on hyperacute rejection. 
  • The effect of metabolic milieu on cardiac PET imaging using fluorine-18-deoxyglucose and nitrogen-13-ammonia in normal volunteers. 
  • The effect of soluble complement receptor type 1 on hyperacute xenograft rejection. 
  • The effect of tactile stimulation on serum growth hormone and tissue ornithine decarboxylase activity during maternal deprivation in rat pups. 
  • The effects of atrial fibrillation on myocardial blood flow and energetics. 
  • The effects of ventricular pacing on left ventricular geometry, function, myocardial oxygen consumption, and efficiency of contraction in conscious dogs. 
  • The extracellular matrix protein agrin promotes heart regeneration in mice. 
  • The failing heart utilizes 3-hydroxybutyrate as a metabolic stress defense. 
  • The influence of pH on th electrophysiological effects of lidocaine in guinea pig ventricular myocardium. 
  • The involvement of superoxide and iNOS-derived NO in cardiac dysfunction induced by pro-inflammatory cytokines. 
  • The junctophilin family of proteins: from bench to bedside. 
  • The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy. 
  • The low molecular weight GTPase Rho regulates myofibril formation and organization in neonatal rat ventricular myocytes. Involvement of Rho kinase. 
  • The mammalian Tolloid-like 1 gene, Tll1, is necessary for normal septation and positioning of the heart. 
  • The multiple membrane spanning topography of the beta 2-adrenergic receptor. Localization of the sites of binding, glycosylation, and regulatory phosphorylation by limited proteolysis. 
  • The new age of medical genomics. 
  • The nitric oxide synthase inhibitor N(G)-nitro-L-arginine decreases defibrillation-induced free radical generation. 
  • The nitric oxide synthase inhibitor N(G)-nitro-L-arginine decreases defibrillation-induced free radical generation. 
  • The p38 mitogen-activated protein kinase pathway--a potential target for intervention in infarction, hypertrophy, and heart failure. 
  • The perfusion of isolated whole organs. 
  • The porcine heart M2 muscarinic receptor: agonist-induced phosphorylation and comparison of properties with the chick heart receptor. 
  • The rate of mitochondrial mutagenesis is faster in mice than humans. 
  • The real estate of cardiac signaling: location, location, location. 
  • The relationship between cardiac endothelium and fibroblasts: it's complicated. 
  • The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data. 
  • The right ventricular transcriptome signature in Ossabaw swine with cardiometabolic heart failure: implications for the coronary vasculature. 
  • The role of mechanical and humoral factors in growth regulation of vascular smooth muscle and cardiac myocytes. 
  • The role of the Grb2-p38 MAPK signaling pathway in cardiac hypertrophy and fibrosis. 
  • The small molecule Chicago Sky Blue promotes heart repair following myocardial infarction in mice. 
  • The spectrum of dilated cardiomyopathy. The Johns Hopkins experience with 1,278 patients. 
  • The structural proteins of normal and diseased human myocardium. 
  • The two-pore domain potassium channel TREK-1 mediates cardiac fibrosis and diastolic dysfunction. 
  • The ubiquitin ligase MuRF1 regulates PPARα activity in the heart by enhancing nuclear export via monoubiquitination. 
  • The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. 
  • The variable natural history of idiopathic dilated cardiomyopathy. 
  • The winged-helix/forkhead protein myocyte nuclear factor beta (MNF-beta) forms a co-repressor complex with mammalian sin3B. 
  • Theophylline produces an adverse effect on myocardial lactate metabolism at a therapeutic serum concentration: an effect blocked by verapamil. 
  • Theoretical basis for sodium and potassium MRI of the human heart at 1.5 T. 
  • Therapeutic Effect of Targeting Branched-Chain Amino Acid Catabolic Flux in Pressure-Overload Induced Heart Failure. 
  • Therapeutic microparticles functionalized with biomimetic cardiac stem cell membranes and secretome. 
  • Thermal-perfusion balloon coronary angioplasty: in vivo evaluation. 
  • Three-dimensional tissue-engineered human skeletal muscle model of Pompe disease. 
  • Thyroid hormone differentially regulates cellular development in neonatal rat heart and kidney. 
  • Thyroid hormone differentially regulates development of beta-adrenergic receptors, adenylate cyclase and ornithine decarboxylase in rat heart and kidney. 
  • Thyroid hormone regulates ontogeny of beta adrenergic receptors and adenylate cyclase in rat heart and kidney: effects of propylthiouracil-induced perinatal hypothyroidism. 
  • Thyroid hormone regulation of alpha-adrenergic receptors: studies in rat myocardium. 
  • Thyroid hormone regulation of beta-adrenergic receptor number. 
  • Thyroxine and propylthiouracil effects on alpha- and beta-adrenergic receptor number, ATPase activities, and sialic acid content of rat cardiac membrane vesicles. 
  • Tissue angiotensin system in cardiovascular medicine. A paradigm shift? 
  • Tissue engineering in the cardiovascular system: progress toward a tissue engineered heart. 
  • Tissue engineering of functional cardiac muscle: molecular, structural, and electrophysiological studies. 
  • Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure. 
  • Tissue-specific inactivation of murine M6P/IGF2R. 
  • Tissue-specific regulation of renin expression in the mouse. 
  • Tnni3k modifies disease progression in murine models of cardiomyopathy. 
  • To excite a heart: a bird's view. 
  • Top-down quantitative proteomics identified phosphorylation of cardiac troponin I as a candidate biomarker for chronic heart failure. 
  • Topical anesthesia with EMLA reduces pain during endomyocardial biopsy: a randomized trial. 
  • Toxic effects of maternal methadone administration on cardiac development in the neonatal rat: potential participation of altered polyamine levels in growth impairment. 
  • Tp53 Suppression Promotes Cardiomyocyte Proliferation during Zebrafish Heart Regeneration. 
  • Transcriptomic biomarkers for individual risk assessment in new-onset heart failure. 
  • Transgenic manipulation of myocardial G protein-coupled receptors and receptor kinases. 
  • Transgenic mice with cardiac overexpression of alpha1B-adrenergic receptors. In vivo alpha1-adrenergic receptor-mediated regulation of beta-adrenergic signaling. 
  • Transgenic overexpression of the Ca2+-binding protein S100A1 in the heart leads to increased in vivo myocardial contractile performance. 
  • Transmethylamine-N-Oxide Is Associated With Diffuse Cardiac Fibrosis in People Living With HIV. 
  • Transplantation of embryonic stem cells into the infarcted mouse heart: formation of multiple cell types. 
  • Transverse shape characteristics of cardiac myocytes from rats and humans. 
  • Treatment strategies for microvascular dysfunction following acute myocardial infarction. 
  • Two-dimensional echocardiographic assessment of mitral stenosis. 
  • UDP-N-acetylglucosamine transferase and glutamine: fructose 6-phosphate amidotransferase activities in insulin-sensitive tissues. 
  • Ultrastructural studies of unstable angina in living man. 
  • Ultrastructure of heart muscle. 
  • Uncoupling of G-protein coupled receptors in vivo: insights from transgenic mice. 
  • Understanding and recognizing cardiac amyloidosis. 
  • Unitary sodium channels in isolated cardiac myocytes of rabbit. 
  • Untargeted metabolomics analysis of ischemia-reperfusion-injured hearts ex vivo from sedentary and exercise-trained rats. 
  • Upake of plasma lipids by extrahepatic tissues of vitamin A fed rats. 
  • Uptake mechanisms of meta-[123I]iodobenzylguanidine in isolated rat heart. 
  • Use of an isolated heart model to test the utilization of substrates for inclusion in cardioplegic solutions. 
  • Use of cardiac magnetic resonance imaging to evaluate cardiac structure, function and fibrosis in children with infantile Pompe disease on enzyme replacement therapy. 
  • Use of cardiac magnetic resonance to assess viability. 
  • Use of donor serum to prevent passive transfer of hyperacute rejection. 
  • Usefulness of combining necrosis and platelet markers in triaging patients presenting with chest pain to the emergency department. 
  • Validation of 19F-magnetic resonance determination of myocardial blood volume. 
  • Validation of in vivo two-dimensional echocardiographic dimension measurements using myocardial mass estimates in dogs. 
  • Validation of sub-segmental visual scoring for the quantification of ischemic and nonischemic myocardial fibrosis using late gadolinium enhancement MRI. 
  • Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-IIa Investigators. 
  • Vasodilator therapy in acute myocardial infarction. A comparison of sodium nitroprusside and nitroglycerin. 
  • Vegfaa instructs cardiac muscle hyperplasia in adult zebrafish. 
  • Ventricular and myocardial efficiencies during acute aortic regurgitation in conscious dogs. 
  • Ventricular expression of a MLC-2v-ras fusion gene induces cardiac hypertrophy and selective diastolic dysfunction in transgenic mice. 
  • Very low calorie diets: their efficacy, safety, and future. 
  • Very-long-chain acyl-coenzyme a dehydrogenase deficiency in mice. 
  • Viability assessment by delayed enhancement cardiovascular magnetic resonance: will low-dose dobutamine dull the shine? 
  • Video-assisted thoracoscopic transplantation of myoblasts into the heart. 
  • Viral hemorrhagic septicemia virus, Ichthyophonus hoferi, and other causes of morbidity in Pacific herring Clupea pallasi spawning in Prince William Sound, Alaska, USA. 
  • Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. 
  • Vitamin A and biochemical development. II. Effect of postnatal excess vitamin-A administration on the activity of pyridine nucleotide-linked dehydrogenases. 
  • Voltage-independent effects of extracellular K+ on the Na+ current and phase 0 of the action potential in isolated cardiac myocytes. 
  • What the dead can teach the living: systemic nature of heart failure with preserved ejection fraction. 
  • Widely disseminated Cunninghamella mucormycosis in an adult renal transplant patient: case report and review of the literature. 
  • Wnt2 coordinates the commitment of mesoderm to hematopoietic, endothelial, and cardiac lineages in embryoid bodies. 
  • Zebrafish have an ethanol-inducible hepatic 4-nitrophenol hydroxylase that is not CYP2E1-like. 
  • beta-Adrenergic action on wild-type and KPQ mutant human cardiac Na+ channels: shift in gating but no change in Ca2+:Na+ selectivity. 
  • beta-Adrenergic modulation of muscarinic cholinergic receptor expression and function in developing heart. 
  • beta-Arrestin-mediated PDE4 cAMP phosphodiesterase recruitment regulates beta-adrenoceptor switching from Gs to Gi. 
  • beta2 adrenoceptor gene therapy ameliorates left ventricular dysfunction following cardiac surgery. 
  • c-Jun N-terminal kinase activation mediates downregulation of connexin43 in cardiomyocytes. 
  • mRNA Metabolism in Cardiac Development and Disease: Life After Transcription. 
  • microRNA-21-5p dysregulation in exosomes derived from heart failure patients impairs regenerative potential. 
  • p38 MAP kinases in the heart. 
  • p38 Mitogen-activated protein kinase mediates a negative inotropic effect in cardiac myocytes. 
  • p38 Mitogen-activated protein kinase regulates chamber-specific perinatal growth in heart. 
  • p53 functions in endothelial cells to prevent radiation-induced myocardial injury in mice. 
  • pH dependence of [3H]norepinephrine uptake into catecholamine storage vesicles isolated from rat brain, heart and adrenal medulla. 
  • pH dependence of kinetics and steady-state block of cardiac sodium channels by lidocaine. 
  • pKa does not predict pH potentiation of sodium channel blockade by lidocaine and W6211 in guinea pig ventricular myocardium. 
  • zebraflash transgenic lines for in vivo bioluminescence imaging of stem cells and regeneration in adult zebrafish. 
  • Β-arrestin: a signaling molecule and potential therapeutic target for heart failure. 
  • β-Arrestin-biased AT1R stimulation promotes cell survival during acute cardiac injury. 
• 

  Keywords of People

  • Alexander, John Hunter Peel, Professor of Medicine, Medicine, Cardiology
  • Badea, Cristian Tudorel, Professor in Radiology, Biomedical Engineering
  • Barker, Piers Christopher Andrew, Professor of Pediatrics, Pediatrics, Cardiology
  • Bennett, Vann, George Barth Geller Distinguished Professor of Molecular Biology, Duke Cancer Institute
  • Bradford, William Dalton, Professor of Pathology, Pathology
  • Case, Laura Elizabeth, Associate Professor in Orthopaedic Surgery, Pediatrics, Medical Genetics
  • Chen, Jun, Professor of Medicine, Duke Cancer Institute
  • Erickson, Harold Paul, James B. Duke Distinguished Professor Emeritus, Cell Biology
  • Henriquez, Craig S., Professor of Biomedical Engineering, Biomedical Engineering
  • Hirschey, Matthew, Associate Professor of Medicine, Cell Biology
  • Hogan, Brigid L. M., Research Professor of Cell Biology, Cell Biology
  • Mentz, Robert John, Associate Professor of Medicine, Medicine, Cardiology
  • Milano, Carmelo Alessio, Joseph W. and Dorothy W. Beard Distinguished Professor of Experimental Surgery, Surgery, Cardiovascular and Thoracic Surgery
  • Nielsen, Karen Cristina, Associate Professor of Anesthesiology, Anesthesiology, Ambulatory
  • O'Connor, Christopher Michael, Adjunct Professor in the Department of Medicine, Medicine, Clinical Pharmacology
  • Pitt, Geoffrey Stuart, Adjunct Professor in the Department of Medicine, Medicine, Cardiology
  • Starmer, Charles Franklin, Professor Emeritus of Computer Science, Computer Science
  • Turkington, Timothy Garvey, Associate Professor in Radiology, Radiology